<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Hum Reprod</journal-id><journal-id journal-id-type="publisher-id">molehr</journal-id><journal-id journal-id-type="hwp">molehr</journal-id><journal-title-group><journal-title>Molecular Human Reproduction</journal-title></journal-title-group><issn pub-type="ppub">1360-9947</issn><issn pub-type="epub">1460-2407</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/molehr/gap072</article-id><article-id pub-id-type="publisher-id">gap072</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Prodoehl</surname><given-names>Mark J.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hatzirodos</surname><given-names>Nicholas</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Irving-Rodgers</surname><given-names>Helen F.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Zhen Z.</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Painter</surname><given-names>Jodie N.</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hickey</surname><given-names>Theresa E.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gibson</surname><given-names>Mark A.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rainey</surname><given-names>William E.</given-names></name><xref ref-type="aff" rid="af4">4</xref><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Carr</surname><given-names>Bruce R.</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Mason</surname><given-names>Helen D.</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Norman</surname><given-names>Robert J.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Montgomery</surname><given-names>Grant W.</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Rodgers</surname><given-names>Raymond J.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="corresp" rid="cor1">7</xref></contrib></contrib-group><aff id="af1"><label>1</label><addr-line>Research Centre for Reproductive Health, Robinson Institute and School of Paediatrics and Reproductive Health</addr-line>, <institution>University of Adelaide</institution>, <addr-line>Adelaide, SA 5005</addr-line>, <country>Australia</country></aff><aff id="af2"><label>2</label><addr-line>School of Medical Sciences</addr-line>, <institution>University of Adelaide</institution>, <addr-line>Adelaide, SA 5005</addr-line>, <country>Australia</country></aff><aff id="af3"><label>3</label><addr-line>Molecular Epidemiology</addr-line>, <institution>Queensland Institute of Medical Research</institution>, <addr-line>Brisbane, QLD 4029</addr-line>, <country>Australia</country></aff><aff id="af4"><label>4</label><addr-line>Department of Physiology</addr-line>, <institution>Medical College of Georgia</institution>, <addr-line>Augusta, GA 30912</addr-line>, <country>USA</country></aff><aff id="af5"><label>5</label><addr-line>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology</addr-line>, <institution>University of Texas Southwestern Medical Center at Dallas</institution>, <addr-line>Dallas, TX 75390-9032</addr-line>, <country>USA</country></aff><aff id="af6"><label>6</label><addr-line>Division of Basic Medical Sciences</addr-line>, <institution>St. George's University of London</institution>, <addr-line>Cranmer Terrace, London SW17 0RE</addr-line>, <country>UK</country></aff><author-notes><corresp id="cor1"><label>7</label>Correspondence address. E-mail: <email>ray.rodgers@adelaide.edu.au</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>8</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>8</month><year>2009</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>15</volume><issue>12</issue><issue-title>Special Issue: The ovary: from basic research to clinic</issue-title><fpage>829</fpage><lpage>841</lpage><history><date date-type="received"><day>13</day><month>5</month><year>2009</year></date><date date-type="rev-recd"><day>11</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>17</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology</copyright-statement><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.5/uk/">http://creativecommons.org/licenses/by-nc/2.5/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Several studies have demonstrated an association between polycystic ovary syndrome (PCOS) and the dinucleotide repeat microsatellite marker D19S884, which is located in intron 55 of the fibrillin-3 (<italic>FBN3</italic>) gene. Fibrillins, including FBN1 and 2, interact with latent transforming growth factor (TGF)-&#x003b2;-binding proteins (LTBP) and thereby control the bioactivity of TGF&#x003b2;s. TGF&#x003b2;s stimulate fibroblast replication and collagen production. The PCOS ovarian phenotype includes increased stromal collagen and expansion of the ovarian cortex, features feasibly influenced by abnormal fibrillin expression. To examine a possible role of fibrillins in PCOS, particularly FBN3, we undertook tagging and functional single nucleotide polymorphism (SNP) analysis (32 SNPs including 10 that generate non-synonymous amino acid changes) using DNA from 173 PCOS patients and 194 controls. No SNP showed a significant association with PCOS and alleles of most SNPs showed almost identical population frequencies between PCOS and control subjects. No significant differences were observed for microsatellite D19S884. In human PCO stroma/cortex (<italic>n</italic> = 4) and non-PCO ovarian stroma (<italic>n</italic> = 9), follicles (<italic>n</italic> = 3) and corpora lutea (<italic>n</italic> = 3) and in human ovarian cancer cell lines (KGN, SKOV-3, OVCAR-3, OVCAR-5), <italic>FBN1</italic> mRNA levels were approximately 100 times greater than <italic>FBN2</italic> and 200&#x02013;1000-fold greater than <italic>FBN3</italic>. Expression of <italic>LTBP-1</italic> mRNA was 3-fold greater than <italic>LTBP-2</italic>. We conclude that <italic>FBN3</italic> appears to have little involvement in PCOS but cannot rule out that other markers in the region of chromosome 19p13.2 are associated with PCOS or that <italic>FBN3</italic> expression occurs in other organs and that this may be influencing the PCOS phenotype.</p></abstract><kwd-group><kwd>fibrillin</kwd><kwd>latent-transforming growth factor &#x003b2;-binding protein</kwd><kwd>polycystic ovary syndrome</kwd><kwd>ovary</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects an estimated 5&#x02013;7% of women of reproductive age in western societies and is characterized by hyperandrogenemia, chronic anovulation and polycystic ovaries (<xref ref-type="bibr" rid="GAP072C28">Knochenhauer <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="GAP072C11">Diamanti-Kandarakis <italic>et al</italic>., 1999</xref>). Hirsuitism is common among women who suffer from the disorder, and they are at increased risk of anovulatory infertility, obesity (<xref ref-type="bibr" rid="GAP072C9">Conway <italic>et al</italic>., 1989</xref>; <xref ref-type="bibr" rid="GAP072C3">Balen <italic>et al</italic>., 1995</xref>), hyperlipidaemia and predisposing factors for heart disease (<xref ref-type="bibr" rid="GAP072C53">Wild <italic>et al</italic>., 1985</xref>; <xref ref-type="bibr" rid="GAP072C52">Wild and Bartholomew, 1988</xref>; <xref ref-type="bibr" rid="GAP072C40">Slowinska-Srzednicka <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="GAP072C54">Wild <italic>et al</italic>., 1992</xref>; <xref ref-type="bibr" rid="GAP072C41">Talbott <italic>et al</italic>., 1995</xref>) and type II diabetes (<xref ref-type="bibr" rid="GAP072C28">Knochenhauer <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="GAP072C11">Diamanti-Kandarakis <italic>et al</italic>., 1999</xref>). While the aetiology of PCOS is unknown, familial studies have demonstrated heritability of the disorder, suggesting that there is a genetic component (reviewed in <xref ref-type="bibr" rid="GAP072C2">Amato and Simpson, 2004</xref>). Female first-degree relatives display strong association between the metabolic abnormalities of PCOS and hyperandrogenemia (<xref ref-type="bibr" rid="GAP072C30">Legro <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="GAP072C55">Yildiz <italic>et al</italic>., 2003</xref>), and a recent study demonstrated that the brothers of women with PCOS also have a strong association with metabolic abnormalities (<xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>). This suggests a common genetic association between the metabolic features of PCOS and hyperandrogenemia, whether that be a defect in the same gene or multiple genes in the same pathway.</p><p>The mode of inheritance of PCOS has proven difficult to determine suggesting that the disorder is a complex trait possibly involving multiple genes and/or environmental influences. Many genes in the steroid synthesis pathways (<xref ref-type="bibr" rid="GAP072C7">Carey <italic>et al</italic>., 1994</xref>; <xref ref-type="bibr" rid="GAP072C15">Gharani <italic>et al</italic>., 1997</xref>), the regulatory pathways of gonadotrophin action (<xref ref-type="bibr" rid="GAP072C13">Franks, 1995</xref>) and the insulin-signalling pathway have been investigated for association with the disorder. Many of these studies, however, have proven inconclusive or are not reproducible. In contrast, several studies using independent patient cohorts have demonstrated a significant association between PCOS and the dinucleotide repeat microsatellite marker D19S884, which is located 1cM upstream of the insulin receptor (<italic>INSR</italic>) gene in chromosome region19p13.2 (<xref ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="GAP072C49">Villuendas <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="GAP072C46">Urbanek <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>). The distance of this marker from <italic>INSR</italic> casts doubt upon the likelihood of there being a causal genetic variant within <italic>INSR</italic> and it is more probable that variant(s) in a distal enhancer of <italic>INSR</italic> or an unrelated gene are the reason for the association between D19S884 and PCOS. D19S884 is located within intron 55 of the fibrillin-3 gene (<italic>FBN3</italic>).</p><p>Fibrillins and latent TGF-&#x003b2;-binding proteins (LTBPs) form a family of proteins that are characterized by a modular domain structure comprising epidermal growth factor-like (EGF) domains, calcium-binding EGF domains and unique cysteine-rich TB domains. Three fibrillin genes, <italic>FBN1, 2</italic> and <italic>3</italic> (<xref ref-type="bibr" rid="GAP072C39">Sakai <italic>et al</italic>., 1986</xref>; <xref ref-type="bibr" rid="GAP072C29">Lee <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="GAP072C10">Corson <italic>et al</italic>., 2004</xref>), and four LTBP genes, <italic>LTBP 1, 2, 3</italic> and <italic>4</italic> (<xref ref-type="bibr" rid="GAP072C25">Kanzaki <italic>et al</italic>., 1990</xref>; <xref ref-type="bibr" rid="GAP072C34">Moren <italic>et al</italic>., 1994</xref>; <xref ref-type="bibr" rid="GAP072C56">Yin <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="GAP072C17">Giltay <italic>et al</italic>., 1997</xref>), have been identified in mammals, although in rodents <italic>FBN3</italic> has been disrupted due to chromosomal rearrangements (<xref ref-type="bibr" rid="GAP072C10">Corson <italic>et al</italic>., 2004</xref>). <italic>FBN3</italic> is most highly expressed in human fetal tissues and the human adult brain, eye, lung, adrenal glands, stomach and ovaries (<xref ref-type="bibr" rid="GAP072C51">Wheeler <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="GAP072C10">Corson <italic>et al</italic>., 2004</xref>). Studies of <italic>FBN1</italic> and <italic>2</italic> have shown that they function as structural components of elastin fibres or mircrofibrils and as regulators of TGF-&#x003b2; family members. Regulation of TGF-&#x003b2; activity by the fibrillins is a result of their ability to bind to LTBPs causing sequestration of latent TGF-&#x003b2;s into the extracellular matrix where they are stored and/or activated (<xref ref-type="bibr" rid="GAP072C38">Ramirez and Pereira, 1999</xref>; <xref ref-type="bibr" rid="GAP072C27">Kielty <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="GAP072C35">Neptune <italic>et al</italic>., 2003</xref>). However, there are subtle differences between them. For instance, LTBP-2 itself does not bind latent TGF-&#x003b2;s (<xref ref-type="bibr" rid="GAP072C16">Gibson <italic>et al</italic>., 1995</xref>), but can competitively replace LTBP-1 bound to FBN1 (<xref ref-type="bibr" rid="GAP072C21">Hirani <italic>et al</italic>., 2007</xref>). LTBPs are also required for the correct secretion and folding of TGF-&#x003b2;s (<xref ref-type="bibr" rid="GAP072C33">Miyazono <italic>et al</italic>., 1991</xref>). To date, interactions between FBN3 and LTBPs have not been investigated. Clinical consequences of the disruption of the interaction between the fibrillins and TGF-&#x003b2;s have been reported previously in the pathogenesis of Marfan's syndrome, a connective tissue disorder affecting the limbs, the heart, the lungs and the eyes. Mutations in <italic>FBN1</italic> or the TGF-&#x003b2; type 2 receptor cause Marfan's syndrome (<xref ref-type="bibr" rid="GAP072C5">Boileau <italic>et al</italic>., 2005</xref>). The ability of mutations in <italic>FBN1</italic> to phenocopy those in TGF-&#x003b2;R type 2 suggests that the structural role of FBN1 in the formation of elastic fibres and microfibrils is less critical to the pathology of the disease than its role in regulating the bioavailability of TGF-&#x003b2; family members.</p><p>The involvement of the TGF-&#x003b2; superfamily in the development of PCOS has been implied from functional data (<xref ref-type="bibr" rid="GAP072C18">Glister <italic>et al</italic>., 2005</xref>, <xref ref-type="bibr" rid="GAP072C19">2006</xref>) and the association of several members, including anti-Mullerian hormone (AMH), activin, inhibin and their associated receptors, as well as follistatin, and the SMADS, has been examined (<xref ref-type="bibr" rid="GAP072C44">Urbanek <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="GAP072C45">Urbanek <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="GAP072C26">Kevenaar <italic>et al</italic>., 2008</xref>). Strong association of these genes with PCOS has not been demonstrated, however, it has been suggested that both follistatin, which like fibrillins and LTBPs, contain a TB domain (<xref ref-type="bibr" rid="GAP072C42">Thompson <italic>et al</italic>., 2005</xref>), and AMH may contribute to the severity of the PCOS phenotype by influencing androgen levels and/or follicle development (<xref ref-type="bibr" rid="GAP072C45">Urbanek <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="GAP072C24">Jones <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="GAP072C26">Kevenaar <italic>et al</italic>., 2008</xref>). Women with PCOS not only display aberrant follicle maturation, but also develop a thickening of the tunica albuginea and stromal tissues of their ovaries that is associated with an increase of collagen deposition in these regions (<xref ref-type="bibr" rid="GAP072C22">Hughesdon, 1982</xref>). TGF-&#x003b2; superfamily members have been implicated in the regulation of collagen synthesis by fibroblasts in fibroses; TGF-&#x003b2; promotes collagen expression and fibrosis while bone morphogenic protein (BMP)7 suppresses these effects (<xref ref-type="bibr" rid="GAP072C20">Govinden and Bhoola, 2003</xref>; <xref ref-type="bibr" rid="GAP072C50">Wang <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="GAP072C58">Zeisberg <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="GAP072C48">Verrecchia and Mauviel, 2004</xref>; <xref ref-type="bibr" rid="GAP072C8">Christner and Ayitey, 2006</xref>). Hence we have considered the possibility that the fibrillin/LTBP protein family members may be involved in both the gross ovarian morphological and follicular developmental defects associated with PCOS through a disruption in fibrillin-LTBP interactions resulting in perturbations in TGF-&#x003b2; signalling pathways. For these reasons, we chose to undertake a case&#x02013;control PCOS association test of 32 single nucleotide polymorphisms (SNPs) within <italic>FBN3</italic>. We included non-synonymous SNPs located in the coding region of the gene with the aim of identifying PCOS-associated <italic>FBN3</italic> variants that may lead to disrupted protein function. We also examined the RNA expression profiles of fibrillin/LTBP family members in human ovarian tissues and cell lines.</p></sec><sec id="s2" sec-type="methods"><title>Materials and Methods</title><sec id="s2a"><title>Subjects for DNA genotyping</title><p>Ethics approval for this study was obtained from the University of Adelaide Human Research Ethics Committee. Case subjects were recruited from infertility and antenatal clinics at The Queen Elizabeth Hospital in Adelaide, South Australia, after approval by the ethics committee of North Western Adelaide Health Services. Details of a number of these subjects have been reported previously (<xref ref-type="bibr" rid="GAP072C32">Milner <italic>et al</italic>. 1999</xref>). The study group represented women of various European cultural backgrounds who generally can be classified as Caucasian. Case subjects consisted of women with PCOS defined as hyperandrogenism and chronic anovulation as per the 1990 NIH consensus criteria (<xref ref-type="bibr" rid="GAP072C57">Zawadski and Dunaif, 1992</xref>). Polycystic ovaries were identified on ultrasound and defined as the presence of at least eight peripheral cysts less than 10 mm in diameter, with increased ovarian stroma occurring bilaterally (<xref ref-type="bibr" rid="GAP072C1">Adams <italic>et al</italic>., 1986</xref>). A total of 367 women between the ages of 18 and 42 were recruited and of these, 173 (47%) women fulfilled the criteria for PCOS. A further 86 patients from the same clinics but who had none of the characteristics of PCOS, and largely male-factor related reasons for infertility, served as controls. An additional 108 patients whose PCO status was unknown were recruited from the female blood donor population (<xref ref-type="bibr" rid="GAP072C32">Milner <italic>et al</italic>., 1999</xref>). All samples were de-identified for further analysis.</p></sec><sec id="s2b"><title>DNA extraction</title><p>Peripheral blood lymphocytes were purified from whole blood using Lymphoprep (Nycomed Pharma, Oslo, Norway) and kept frozen in saline at &#x02212;20&#x000b0;C until DNA extraction. DNA was extracted from this tissue using a DNeasy Kit (QIAGEN, Chatsworth, CA) as per the manufacturer's protocol, quantified by spectrophotometry and stored at &#x02212;20&#x000b0;C.</p></sec><sec id="s2c"><title>Analyses of SNPs</title><p>We typed a single multiplex of 32 tagging and functional SNPs spanning an 82 kb region of <italic>FBN3</italic>. Tagging SNPs (a set of SNPs that through high linkage disequilibrium (LD) capture the variation in other common SNPs in the region) were chosen using genotyping data from the International HapMap Project (<uri xlink:type="simple" xlink:href="http://www.hapmap.org/">http://www.hapmap.org/</uri>) from a population of Caucasian and European background (CEU), having minor allelic frequencies of &#x0003e;0.05 and <italic>r</italic><sup>2</sup> values of &#x0003e;0.8. Additional functional SNPs that produce a change in protein sequence were chosen to complete the multiplex using genotyping data from the SNP database at the National Library of Medicine (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/snp">http://www.ncbi.nlm.nih.gov/snp</uri>), such that they would not interfere with the multiplexing of the tagging SNPs. All SNP sequences were downloaded from the Chip Bioinformatics database (<uri xlink:type="simple" xlink:href="http://snpper.chip.org/">http://snpper.chip.org/</uri>) and the sequences were cross checked with the National Center for Biotechnology Information (NCBI, <uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</uri>) and Sequenom RealSNP databases (<uri xlink:type="simple" xlink:href="https://www.realsnp.com/">https://www.realsnp.com/</uri>) before assay design. Assays were designed for the 32 SNPs using the Sequenom MassARRAY Assay Design software (version 3.1). SNPs were typed using iPLEX &#x02122; Gold chemistry and analysed using a Sequenom MassARRAY Compact Mass Spectrometer (Sequenom Inc, San Diego, CA, USA). The 2.5 &#x000b5;L PCR reactions were performed in standard 384-well plates using 12.5 ng genomic DNA, 0.8 unit of <italic>Taq</italic> polymerase (HotStarTaq, Qiagen, Valencia, CA), 500 &#x000b5;mol of each dNTP, 1.625 mM of MgCl<sub>2</sub> and 100 nmol of each PCR primer (Bioneer, Daejeon, Korea). PCR thermal cycling in an ABI-9700 instrument was 15 min at 94&#x000b0;C, followed by 45 cycles of 20 s at 94&#x000b0;C, 30 s at 56&#x000b0;C and 60 s at 72&#x000b0;C. To the completed PCR reaction, 0.15 U shrimp alkaline phosphatase was added and incubated for 40 min at 37&#x000b0;C followed by inactivation for 5 min at 85&#x000b0;C. A mixture of extension primers was tested to adjust the concentrations of extension primers to equilibrate signal-to-noise ratios in the matrix-assisted laser desorption/ionization &#x02212; time of flight (MALDI-TOF) mass spectrometry prior to use for extension reactions. The post-PCR reactions were performed in a final 5 &#x000b5;l of extension reaction containing 1&#x000d7; termination mix, 1 U DNA polymerase and 570&#x02013; 1240 nM extension primers. A two-step 200 short cycle programme was used for the iPLEX Gold reaction as described in a previously study (<xref ref-type="bibr" rid="GAP072C59">Zhao <italic>et al</italic>., 2006</xref>). The iPLEX reaction products were desalted by diluting samples with 15 &#x000b5;l of water and adding 5 &#x000b5;l of resin (Sequenom Inc, San Diego, CA, USA). The products were spotted on a SpectroChip (Sequenom Inc), and data were processed and analysed by MassARRAY TYPER 3.4 software (Sequenom Inc).</p></sec><sec id="s2d"><title>Microsatellite genotyping</title><p>To detect microsatellite D19S884 alleles we designed our own primers (Table&#x000a0;<xref ref-type="table" rid="GAP072TB1">I</xref>) rather than using those suggested for amplimer AFMa299zc5 listed in Genbank as we found these to be unreliable. Primers were designed using Primer Express software (Applied Biosystems, Foster City, CA, USA), from the published genomic sequence of human <italic>FBN3</italic> (Table&#x000a0;<xref ref-type="table" rid="GAP072TB1">I</xref>). The amplification reactions were performed using 50 ng genomic DNA, 1 U of <italic>Taq</italic> polymerase (AmpliTaq Gold, PE Applied Biosystems) in 1.56 mM MgCl<sub>2</sub>, 0.1 mM of each dNTP and 10 nmol of each primer. The cycling conditions were 95&#x000b0;C initially for 7 min followed by 40 cycles of 95&#x000b0;C, 55&#x000b0;C and 72&#x000b0;C of 30 s each, then a final extension of 30 min at 72&#x000b0;C. The fluorescent PCR products were assayed by capillary electrophoresis and visually analysed using the ABI 3730 DNA Analyser (Applied Biosystems) with GeneScan Analysis software. Allele lengths were confirmed by DNA sequencing of homozygous alleles.</p><table-wrap id="GAP072TB1" position="float"><label>Table&#x000a0;I</label><caption><p>Primers used for qRT&#x02013;PCR and microsatellite genotyping</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene or locus</th><th align="left" rowspan="1" colspan="1">Genebank accession number</th><th align="left" rowspan="1" colspan="1">Location of amplicon</th><th align="left" rowspan="1" colspan="1">Forward primer (5&#x02032;&#x02013;3&#x02032;)</th><th align="left" rowspan="1" colspan="1">Reverse primer (5&#x02032;&#x02013;3&#x02032;)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">18S</td><td rowspan="1" colspan="1">AF176811</td><td rowspan="1" colspan="1">56&#x02013;146</td><td rowspan="1" colspan="1">AGAAACGGCTACCACATCCAA</td><td rowspan="1" colspan="1">CCTGTATTGTTATTTTTCGTCACTACC</td></tr><tr><td rowspan="1" colspan="1">FBN1</td><td rowspan="1" colspan="1">BC146854</td><td rowspan="1" colspan="1">1822-1882</td><td rowspan="1" colspan="1">AGCACACTCACGCGGACA</td><td rowspan="1" colspan="1">AGATCCGGCCATTCTGTAAACA</td></tr><tr><td rowspan="1" colspan="1">FBN2</td><td rowspan="1" colspan="1">NM_001999</td><td rowspan="1" colspan="1">7545-7646</td><td rowspan="1" colspan="1">TCCAGTCAAGTTCTTCAGGCAC</td><td rowspan="1" colspan="1">TGCGACTACTGGATGCCATTT</td></tr><tr><td rowspan="1" colspan="1">FBN3</td><td rowspan="1" colspan="1">NM_032447</td><td rowspan="1" colspan="1">1716-1787</td><td rowspan="1" colspan="1">TGGCGGCCACTACTGCAT</td><td rowspan="1" colspan="1">TTGGTACAGTGGCCGTTCAC</td></tr><tr><td rowspan="1" colspan="1">LTBP-1</td><td rowspan="1" colspan="1">BC130289</td><td rowspan="1" colspan="1">3195-3322</td><td rowspan="1" colspan="1">CCCCAATGTCACGAAACAAGA</td><td rowspan="1" colspan="1">AACCTTTCCCTTTGGGACACA</td></tr><tr><td rowspan="1" colspan="1">LTBP-2</td><td rowspan="1" colspan="1">NM_000428</td><td rowspan="1" colspan="1">3276-3382</td><td rowspan="1" colspan="1">CAGGAAAGGACACTGCCAAGA</td><td rowspan="1" colspan="1">CCTCACAGGCCAGACAAGTGTA</td></tr><tr><td rowspan="1" colspan="1">D19S884</td><td rowspan="1" colspan="1">NC_000019</td><td rowspan="1" colspan="1">62 185&#x02013;62 353</td><td rowspan="1" colspan="1">GGAGTTGCTCAGGGTC</td><td rowspan="1" colspan="1">TCCCTCAACCCCCCGAGTTC</td></tr></tbody></table></table-wrap></sec><sec id="s2e"><title>Statistical analyses</title><p>LD analyses and pairwise LD plots of <italic>D</italic>&#x02032; were generated using the Haploview 3.32 software (<uri xlink:type="simple" xlink:href="http://www.broad.mit.edu/haploview/haploview">http://www.broad.mit.edu/haploview/haploview</uri>) (<xref ref-type="bibr" rid="GAP072C4">Barrett <italic>et al</italic>., 2005</xref>). The statistical power to detect an association in our case&#x02013;control cohort was calculated by post-hoc tests implemented in the G.Power software (<xref ref-type="bibr" rid="GAP072C6">Buchner <italic>et al</italic>., 1997</xref>) for an alpha (<italic>P</italic>-value) of 0.05 over effect sizes ranging from 0.1 (small) to 0.5 (medium). The sample has 60% power to detect an effect size of 0.2 and greater than 88% power for effect sizes of 0.3 or more. Case&#x02013;control association tests for SNP markers were performed using unphased 3.0.10 (<xref ref-type="bibr" rid="GAP072C12">Dudbridge, 2008</xref>). Odds ratios (ORs) with corresponding 95% confidence intervals (95% CI) were calculated using Woolf's formula with Haldane's correction. <italic>P</italic>-values were corrected for multiple comparisons using Bonferroni's correction. Case&#x02013;control association tests for the microsatellite marker D19S884 were performed using Clump 2.3 (<uri xlink:type="simple" xlink:href="www.mds.qmw.ac.uk/statgen/dcurtis/software.html">www.mds.qmw.ac.uk/statgen/dcurtis/software.html</uri>) and Fisher's exact test. <italic>P</italic>-values for Fisher's exact tests were calculated using GraphPad Prism 5.00 for Windows (GraphPad Software, San Diego California USA, <uri xlink:type="simple" xlink:href="www.graphpad.com">www.graphpad.com</uri>) and were Bonferroni corrected for multiple comparisons.</p></sec><sec id="s2f"><title>Tissues for gene expression analyses</title><p>Collection of tissues for gene expression analyses was approved by the Institution Review Boards of the University of Texas Southwestern Medical Center, Dallas, USA, St Georges University of London, England and The University of Adelaide, Australia. Informed written consent was obtained prior to collection of tissues. Tissues were obtained from premenopausal women undergoing procedures for benign gynaecologic conditions. PCOS ovarian phenotype was diagnosed based on the presence of three or more of the following criteria: enlarged ovarian volume (&#x0003e;9 ml), 10 or more follicles of 2&#x02013;8 mm in diameter, increased density and volume of stroma or a thickened tunica (<xref ref-type="bibr" rid="GAP072C31">Mason <italic>et al</italic>., 1994</xref>). Specimens were obtained from ovarian stroma/cortex (<italic>n</italic> = 9 non-PCO and 4 PCO ovarian phenotype), ovarian follicles (<italic>n</italic> = 3, &#x0003e;8 mm diameter) and corpora lutea (<italic>n</italic> = 3). The human ovarian cancer cell lines OVCAR-3, OVCAR-5 and SKOV-3 (ascites derived) originating from ovarian adenocarcinomas were obtained from the ATCC (Manassas, VA, USA) and the granulosa tumour cell line KGN (<xref ref-type="bibr" rid="GAP072C36">Nishi <italic>et al</italic>., 2001</xref>) was obtained with consent from its originators Professors Hajime Nawata and Toshihiko Yanase of Kyushu University and Professor Yoshihiro Nishi of Kurume University. Tissues and cells were either stored in RNAlater (Ambion, Inc., Austin, TX) at &#x02212;20&#x000b0;C, or snap frozen in liquid nitrogen and stored at &#x02212;80&#x000b0;C prior to RNA or protein isolation.</p></sec><sec id="s2g"><title>Gene expression analyses</title><p>Total RNA was isolated from &#x0223c;100 mg wet weight of stored stromal tissue using 1 ml of Trizol (Invitrogen Australia Pty. Ltd., Mt Waverley, VIC, Australia). Briefly, tissue was homogenized for approximately 30 s on ice using a polytron homogenizer before extraction was carried out as per manufacturer's instructions. Ten micrograms of total RNA was treated with 2 U of DNase I (Ambion Inc, Austin, TX, USA) and first-strand complementary DNA (cDNA) was synthesized from the DNase-treated RNA (2.5 &#x000b5;g) using 200 U Superscript III reverse transcriptase (Invitrogen Australia Pty. Ltd.) and 500 ng random hexamers (Geneworks, Thebarton, SA, Australia). Primers were designed against published mRNA sequences using Primer Express software (Applied Biosystems). Primer sequences for human <italic>FBN1, 2</italic> and <italic>3</italic> and, <italic>LTBP-1</italic> and <italic>-2</italic> mRNA are shown in Table&#x000a0;<xref ref-type="table" rid="GAP072TB1">I</xref>. Real-time PCR amplification was performed using an ABI PRISM 7000 sequence detection system (Applied Biosystems) by adding 2.5 &#x000b5;l of appropriately diluted cDNA, 10 &#x000b5;l 2&#x000d7; SYBR green master mix (Applied Biosystems), 7.1 &#x000b5;l water and 0.2 &#x000b5;l of 12.5 &#x000b5;M forward and reverse primers per well. Samples were amplified in duplicate for one cycle at 50&#x000b0;C for 2 min and 95&#x000b0;C for 10 min, followed by 40 cycles of 95&#x000b0;C for 15 s and 60&#x000b0;C for 1 min.</p><p>To generate a standard curve for each PCR assay, DNA standards for each target sequence were prepared by sub-cloning the PCR products of the corresponding target sequence into pCR2.1-TOPO vector (Invitrogen). The plasmid DNA was isolated and quantified using a Nanodrop spectrophotometer (Nanodrop technologies, Wilmington, DE, USA). DNA sequences were verified by automated sequencing (3730 DNA analyser, Applied Biosystems). Concentrations were calculated from absorbance at 260 nm. Plasmid DNA was serially diluted over three logs to establish a standard curve in a range, determined for each sample, which bounded the <italic>C</italic><sub>T</sub> values obtained for samples (between 1 ng/&#x003bc;l and 10 ag/&#x003bc;l). Concentration of each target was generated from the <italic>C</italic><sub>T</sub> and standard curve and was normalized to the concentration of 18S ribosomal RNA in each sample (calculated by the <italic>C</italic><sub>T</sub> and standard curve for 18S). Gene expression of target sequences was subsequently expressed as fmoles target sequence mRNA/nmole 18S ribosomal RNA. For each gene the expression levels were normally distributed and comparisons between each ovarian compartment and between PCO and non-PCO tissues were compared by ANOVA, with no <italic>post hoc</italic> tests necessary as no significant differences were found.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3a"><title>SNP and microsatellite analyses</title><sec id="s3a1"><title>Marker selection</title><p>We successfully genotyped 173 PCOS patients and 194 healthy control subjects for 32 SNPs (Table&#x000a0;<xref ref-type="table" rid="GAP072TB2">II</xref>) within 82 kb of the <italic>FBN3</italic> gene region (gene map in Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F1">1</xref>). We included SNPs (<italic>n</italic> = 10) that result in non-synonymous amino acid changes in the FBN3 protein (Table&#x000a0;<xref ref-type="table" rid="GAP072TB2">II</xref>), with the intention of identifying PCOS-associated <italic>FBN3</italic> mutations that might lead to defects in the functioning of the FBN3 protein either pre- or post-translationally. One SNP (rs17202741) showed no heterogeneity in the population and another (rs12972954) showed significant departures from Hardy&#x02013;Weinberg equilibrium (possibly indicating a problem with the primers used for genotyping). Both were subsequently excluded from further analyses.</p><fig id="GAP072F1" position="float"><label>Figure&#x000a0;1</label><caption><p>Unphased association analysis for 30 SNPs all of which can be mapped within an 82 kb region spanning <italic>FBN3</italic>. Chromosomal position is plotted versus &#x02013;log <italic>P-</italic>value for chi-square tests of association of each marker with PCOS. The dotted lines represent the cut-off mark for <italic>P</italic>-values reaching significance before Bonferroni's correction for multiple testing (<italic>P</italic>&#x02264;0.05 and <italic>P</italic>&#x02264;0.01). The position of introns and exons of the two genes (<italic>CCL25</italic> and <italic>FBN3</italic>) relative to the SNPs analysed are displayed below the graph. Markers are 1 rs2287936, 2 rs10424096, 3 rs17261710, 4 rs2303169, 5 rs17160147, 6 rs12151028, 7 rs7245429, 8 rs7245552, 9 rs12608849, 10 rs12150963, 11 rs3829817, 12 rs3865464, 13 rs33967815, 14 rs10445638, 15 rs3813779, 16 rs8111335, 17 rs12975322, 18 rs4804063, 19 rs2086149, 20 rs35579498, 21 rs4527136, 22 rs35840170, 23 rs3813774, 24 rs12974280, 25 rs8112525, 26 rs2061776, 27 rs7246376, 28 rs12162237, 29 rs7252584 and 30 rs7256533.</p></caption><graphic xlink:href="gap07201"/></fig><table-wrap id="GAP072TB2" position="float"><label>Table&#x000a0;II</label><caption><p>Information on the SNPs examined, including chromosomal and gene location, sequence variation and the frequencies of their minor alleles for both control and PCOS patients, and the <italic>P</italic>-value for deviation of the genotype frequencies from the Hardy&#x02013;Weinberg equilibrium</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Public id<sup>a</sup></th><th align="left" rowspan="2" colspan="1">Chromsomal location<sup>b</sup></th><th align="left" rowspan="2" colspan="1">Gene location</th><th align="left" rowspan="2" colspan="1">Variation#</th><th align="left" rowspan="2" colspan="1">Minor allele#</th><th align="left" rowspan="2" colspan="1">Hardy&#x02013;Weinberg <italic>P</italic>-value<sup>c</sup></th><th align="left" colspan="2" rowspan="1">Allele frequency<sup>d</sup><hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Control</th><th align="left" rowspan="1" colspan="1">Case</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">rs2287937</td><td rowspan="1" colspan="1">8036420</td><td rowspan="1" colspan="1">3&#x02032; UTR</td><td rowspan="1" colspan="1">G/C</td><td rowspan="1" colspan="1">G</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">0.23</td></tr><tr><td rowspan="1" colspan="1"><sup>&#x02020;</sup>rs12972954</td><td rowspan="1" colspan="1">8037849</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">C/T</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">rs10424096</td><td rowspan="1" colspan="1">8041170</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">A/G</td><td rowspan="1" colspan="1">G</td><td rowspan="1" colspan="1">0.36</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">rs17261710</td><td rowspan="1" colspan="1">8042398</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">C/T</td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="1" colspan="1">rs2303169</td><td rowspan="1" colspan="1">8052114</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">G/A</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.47</td></tr><tr><td rowspan="1" colspan="1">rs17160147</td><td rowspan="1" colspan="1">8054042</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">G/C</td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">0.71</td></tr><tr><td rowspan="2" colspan="1"><sup>&#x02020;&#x02020;</sup>rs17202741</td><td rowspan="2" colspan="1">8062366</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">A/C</td><td rowspan="2" colspan="1">C</td><td rowspan="2" colspan="1">&#x02013;</td><td rowspan="2" colspan="1">&#x02013;</td><td rowspan="2" colspan="1">&#x02013;</td></tr><tr><td rowspan="1" colspan="1">AUG(M), CUG(L)</td></tr><tr><td rowspan="1" colspan="1">rs12151028</td><td rowspan="1" colspan="1">8064924</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">G/C</td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">0.88</td></tr><tr><td rowspan="2" colspan="1">rs7245429</td><td rowspan="2" colspan="1">8065362</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">C/A</td><td rowspan="2" colspan="1">A</td><td rowspan="2" colspan="1">0.57</td><td rowspan="2" colspan="1">0.40</td><td rowspan="2" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">CCT(P), CAT(H)</td></tr><tr><td rowspan="2" colspan="1">rs7245552</td><td rowspan="2" colspan="1">8065409</td><td rowspan="2" colspan="1">Silent</td><td rowspan="1" colspan="1">C/A</td><td rowspan="2" colspan="1">C</td><td rowspan="2" colspan="1">0.89</td><td rowspan="2" colspan="1">0.64</td><td rowspan="2" colspan="1">0.64</td></tr><tr><td rowspan="1" colspan="1">CCC(P), CCA(P)</td></tr><tr><td rowspan="2" colspan="1">rs12608849</td><td rowspan="2" colspan="1">8066334</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">T/C</td><td rowspan="2" colspan="1">T</td><td rowspan="2" colspan="1">0.76</td><td rowspan="2" colspan="1">0.25</td><td rowspan="2" colspan="1">0.28</td></tr><tr><td rowspan="1" colspan="1">TTC(F), ATC(I)</td></tr><tr><td rowspan="2" colspan="1">rs12150963</td><td rowspan="2" colspan="1">8066897</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">G/C</td><td rowspan="2" colspan="1">G</td><td rowspan="2" colspan="1">0.07</td><td rowspan="2" colspan="1">0.86</td><td rowspan="2" colspan="1">0.87</td></tr><tr><td rowspan="1" colspan="1">AAC(N), AAG(K)</td></tr><tr><td rowspan="2" colspan="1">rs3829817</td><td rowspan="2" colspan="1">8067450</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">G/A</td><td rowspan="2" colspan="1">A</td><td rowspan="2" colspan="1">0.71</td><td rowspan="2" colspan="1">0.75</td><td rowspan="2" colspan="1">0.77</td></tr><tr><td rowspan="1" colspan="1">CGG(R), CAG(Q)</td></tr><tr><td rowspan="1" colspan="1">rs3865464</td><td rowspan="1" colspan="1">8074340</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">C/T</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">0.68</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="2" colspan="1">rs33967815</td><td rowspan="2" colspan="1">8074545</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">G/A</td><td rowspan="2" colspan="1">A</td><td rowspan="2" colspan="1">0.22</td><td rowspan="2" colspan="1">0.31</td><td rowspan="2" colspan="1">0.32</td></tr><tr><td rowspan="1" colspan="1">GGC(G), AGC(S)</td></tr><tr><td rowspan="1" colspan="1">rs10445638</td><td rowspan="1" colspan="1">8079428</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">G/A</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">rs3813779</td><td rowspan="1" colspan="1">8080650</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">C/T</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">0.23</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1">rs8111335</td><td rowspan="1" colspan="1">8082361</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">T/C</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">0.17</td></tr><tr><td rowspan="2" colspan="1">rs12975322</td><td rowspan="2" colspan="1">8082640</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">G/A</td><td rowspan="2" colspan="1">A</td><td rowspan="2" colspan="1">0.36</td><td rowspan="2" colspan="1">0.75</td><td rowspan="2" colspan="1">0.78</td></tr><tr><td rowspan="1" colspan="1">GTC(V), ATC(I)</td></tr><tr><td rowspan="2" colspan="1">rs4804063</td><td rowspan="2" colspan="1">8082945</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">G/A</td><td rowspan="2" colspan="1">G</td><td rowspan="2" colspan="1">0.41</td><td rowspan="2" colspan="1">0.81</td><td rowspan="2" colspan="1">0.83</td></tr><tr><td rowspan="1" colspan="1">AGT(S), GGT(G)</td></tr><tr><td rowspan="1" colspan="1">rs2086149</td><td rowspan="1" colspan="1">8083620</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">A/G</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">0.27</td><td rowspan="1" colspan="1">0.30</td><td rowspan="1" colspan="1">0.30</td></tr><tr><td rowspan="2" colspan="1">rs35579498</td><td rowspan="2" colspan="1">8089871</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">C/T</td><td rowspan="2" colspan="1">T</td><td rowspan="2" colspan="1">0.86</td><td rowspan="2" colspan="1">0.04</td><td rowspan="2" colspan="1">0.04</td></tr><tr><td rowspan="1" colspan="1">CGG(R), TGG(W)</td></tr><tr><td rowspan="1" colspan="1">rs4527136</td><td rowspan="1" colspan="1">8092519</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">C/T</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.47</td></tr><tr><td rowspan="2" colspan="1">rs35840170</td><td rowspan="2" colspan="1">8094812</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">G/A</td><td rowspan="2" colspan="1">A</td><td rowspan="2" colspan="1">1.00</td><td rowspan="2" colspan="1">0.97</td><td rowspan="2" colspan="1">0.97</td></tr><tr><td rowspan="1" colspan="1">GTC(V), ATC(I)</td></tr><tr><td rowspan="2" colspan="1">rs3813774</td><td rowspan="2" colspan="1">8102499</td><td rowspan="2" colspan="1">Silent</td><td rowspan="1" colspan="1">C/T</td><td rowspan="2" colspan="1">T</td><td rowspan="2" colspan="1">0.35</td><td rowspan="2" colspan="1">0.05</td><td rowspan="2" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">TGC(C), TGT(C)</td></tr><tr><td rowspan="2" colspan="1">rs12974280</td><td rowspan="2" colspan="1">8102508</td><td rowspan="2" colspan="1">Silent</td><td rowspan="1" colspan="1">C/G</td><td rowspan="2" colspan="1">G</td><td rowspan="2" colspan="1">0.57</td><td rowspan="2" colspan="1">0.62</td><td rowspan="2" colspan="1">0.64</td></tr><tr><td rowspan="1" colspan="1">TCC(S), TCG(S)</td></tr><tr><td rowspan="1" colspan="1">rs8112525</td><td rowspan="1" colspan="1">8107051</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">G/A</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.10</td></tr><tr><td rowspan="1" colspan="1">rs2061776</td><td rowspan="1" colspan="1">8108373</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">A/G</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">0.85</td></tr><tr><td rowspan="2" colspan="1">rs7246376</td><td rowspan="2" colspan="1">8109328</td><td rowspan="2" colspan="1">Coding</td><td rowspan="1" colspan="1">C/T</td><td rowspan="2" colspan="1">T</td><td rowspan="2" colspan="1">0.42</td><td rowspan="2" colspan="1">0.80</td><td rowspan="2" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">CCC(P), CTC(L)</td></tr><tr><td rowspan="1" colspan="1">rs12162237</td><td rowspan="1" colspan="1">8113070</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">T/C</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.48</td></tr><tr><td rowspan="1" colspan="1">rs7252584</td><td rowspan="1" colspan="1">8113241</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">G/C</td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">0.20</td></tr><tr><td rowspan="1" colspan="1">rs7256533</td><td rowspan="1" colspan="1">8113721</td><td rowspan="1" colspan="1">Intronic</td><td rowspan="1" colspan="1">T/C</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.54</td><td rowspan="1" colspan="1">0.56</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup>Reference SNP cluster identification number.</p></fn><fn><p><sup>b</sup>Position of nucleotide on chromosome 19 in Build 35 of the human genome from UCSC (<uri xlink:type="simple" xlink:href="www.genome.ucsc.edu">www.genome.ucsc.edu</uri>).</p></fn><fn><p><sup>c</sup><italic>P</italic>-value for deviation of genotype frequencies from Hardy&#x02013;Weinberg equilibrium.</p></fn><fn><p><sup>d</sup>Minor allelic frequency calculated using Haploview software.</p></fn><fn><p><sup>&#x02020;</sup>SNP displaying significant departure from Hardy&#x02013;Weinberg equilibrium.</p></fn><fn><p><sup>&#x02020;&#x02020;</sup>Potential SNP found not to be allelic. # The bases listed are those used in our design of primers and may represent the complimentary bases as listed in the Public Id.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3a2"><title>SNP association analyses</title><p>The results of the Sequenom genotyping analysis are displayed in Table&#x000a0;<xref ref-type="table" rid="GAP072TB3">III</xref>. Relative frequencies for each allele of the 30 SNPs analysed from PCOS and control subjects are summarized. Most alleles showed almost identical population frequencies between PCOS and control subjects. SNP association analyses performed with unphased software (<xref ref-type="bibr" rid="GAP072C12">Dudbridge, 2008</xref>) found only one SNP (rs3813774) that achieved a significant (<italic>P</italic> = 0.04 uncorrected) association with PCOS (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F1">1</xref>). In addition, case&#x02013;control association analysis with Haploview software (<xref ref-type="bibr" rid="GAP072C4">Barrett <italic>et al</italic>., 2005</xref>) found one SNP (rs3813774) that achieved a significant (<italic>P</italic> = 0.04 uncorrected) association with PCOS (Table&#x000a0;<xref ref-type="table" rid="GAP072TB3">III</xref>). Upon correction for multiple comparisons, however, the <italic>P</italic>-value for this SNP no longer reached significance.</p><table-wrap id="GAP072TB3" position="float"><label>Table&#x000a0;III</label><caption><p>Association analysis of SNPs within the <italic>FBN3</italic> gene with PCOS showing chromosomal position, chi-square values, <italic>P</italic>-values, odds ratios, confidence limits and allelic frequencies for each SNP</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Marker id<sup>a</sup></th><th align="left" rowspan="2" colspan="1">Chromosomal postion<sup>b</sup></th><th align="left" rowspan="2" colspan="1"><italic>&#x003c7;</italic><sup>2</sup> (Haploview)<sup>c</sup></th><th align="left" rowspan="2" colspan="1"><italic>P</italic>-value (Haploview)<sup>d</sup></th><th align="left" rowspan="2" colspan="1">&#x02212;log <italic>P</italic>-value</th><th align="left" rowspan="2" colspan="1">Odds ratio<sup>e</sup></th><th align="left" rowspan="2" colspan="1">95% low<sup>f</sup></th><th align="left" rowspan="2" colspan="1">95% high<sup>g</sup></th><th align="left" rowspan="2" colspan="1"><italic>P</italic>-value corrected (Haploview)<sup>h</sup></th><th align="left" colspan="4" rowspan="1">Minor allele<hr/></th><th align="left" colspan="4" rowspan="1">Major allele<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Case frequency</th><th align="left" rowspan="1" colspan="1">Control frequency</th><th align="left" rowspan="1" colspan="1">Case number<sup>i</sup></th><th align="left" rowspan="1" colspan="1">Control number<sup>j</sup></th><th align="left" rowspan="1" colspan="1">Case frequency</th><th align="left" rowspan="1" colspan="1">Control frequency</th><th align="left" rowspan="1" colspan="1">Case number<sup>i</sup></th><th align="left" rowspan="1" colspan="1">Control number<sup>j</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">rs2297936</td><td rowspan="1" colspan="1">8036420</td><td rowspan="1" colspan="1">1.81 (1.92)</td><td rowspan="1" colspan="1">0.18 (0.17)</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">1.28</td><td rowspan="1" colspan="1">0.89</td><td rowspan="1" colspan="1">1.83</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.23</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">0.81</td><td rowspan="1" colspan="1">266</td><td rowspan="1" colspan="1">314</td></tr><tr><td rowspan="1" colspan="1">rs10424096</td><td rowspan="1" colspan="1">8041170</td><td rowspan="1" colspan="1">0.21 (0.11)</td><td rowspan="1" colspan="1">0.64 (0.74)</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">1.15</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">2.04</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">0.93</td><td rowspan="1" colspan="1">0.93</td><td rowspan="1" colspan="1">311</td><td rowspan="1" colspan="1">342</td></tr><tr><td rowspan="1" colspan="1">rs17261710</td><td rowspan="1" colspan="1">8042398</td><td rowspan="1" colspan="1">0.17 (0.20)</td><td rowspan="1" colspan="1">0.68 (0.66)</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0.63</td><td rowspan="1" colspan="1">1.35</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.18</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">0.82</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">285</td><td rowspan="1" colspan="1">324</td></tr><tr><td rowspan="1" colspan="1">rs2303169</td><td rowspan="1" colspan="1">8052114</td><td rowspan="1" colspan="1">1.08 (1.08)</td><td rowspan="1" colspan="1">0.30 (0.30)</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">0.63</td><td rowspan="1" colspan="1">1.17</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.47</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">163</td><td rowspan="1" colspan="1">169</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">181</td><td rowspan="1" colspan="1">219</td></tr><tr><td rowspan="1" colspan="1">rs17160147</td><td rowspan="1" colspan="1">8054042</td><td rowspan="1" colspan="1">0.03 (0.03)</td><td rowspan="1" colspan="1">0.85 (0.85)</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">1.03</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">1.43</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.30</td><td rowspan="1" colspan="1">0.30</td><td rowspan="1" colspan="1">101</td><td rowspan="1" colspan="1">117</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">241</td><td rowspan="1" colspan="1">271</td></tr><tr><td rowspan="1" colspan="1">rs12151028</td><td rowspan="1" colspan="1">8064924</td><td rowspan="1" colspan="1">0.32 (0.32)</td><td rowspan="1" colspan="1">0.57 (0.57)</td><td rowspan="1" colspan="1">0.24</td><td rowspan="1" colspan="1">1.13</td><td rowspan="1" colspan="1">0.72</td><td rowspan="1" colspan="1">1.77</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">301</td><td rowspan="1" colspan="1">334</td></tr><tr><td rowspan="1" colspan="1">rs7245429</td><td rowspan="1" colspan="1">8065362</td><td rowspan="1" colspan="1">0.41 (0.41)</td><td rowspan="1" colspan="1">0.52 (0.52)</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">0.91</td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">1.22</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.42</td><td rowspan="1" colspan="1">0.39</td><td rowspan="1" colspan="1">142</td><td rowspan="1" colspan="1">153</td><td rowspan="1" colspan="1">0.58</td><td rowspan="1" colspan="1">0.61</td><td rowspan="1" colspan="1">198</td><td rowspan="1" colspan="1">235</td></tr><tr><td rowspan="1" colspan="1">rs7245552</td><td rowspan="1" colspan="1">8065409</td><td rowspan="1" colspan="1">0.002 (0.002)</td><td rowspan="1" colspan="1">0.96 (0.96)</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.73</td><td rowspan="1" colspan="1">1.35</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.36</td><td rowspan="1" colspan="1">0.36</td><td rowspan="1" colspan="1">121</td><td rowspan="1" colspan="1">138</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">219</td><td rowspan="1" colspan="1">248</td></tr><tr><td rowspan="1" colspan="1">rs12608849</td><td rowspan="1" colspan="1">8066334</td><td rowspan="1" colspan="1">1.05 (1.05)</td><td rowspan="1" colspan="1">0.31 (0.31)</td><td rowspan="1" colspan="1">0.51</td><td rowspan="1" colspan="1">1.19</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">1.64</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">0.72</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">245</td><td rowspan="1" colspan="1">288</td></tr><tr><td rowspan="1" colspan="1">rs12150963</td><td rowspan="1" colspan="1">8066897</td><td rowspan="1" colspan="1">0.21 (0.21)</td><td rowspan="1" colspan="1">0.65 (0.65)</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">0.90</td><td rowspan="1" colspan="1">0.58</td><td rowspan="1" colspan="1">1.42</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">0.87</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">299</td><td rowspan="1" colspan="1">333</td></tr><tr><td rowspan="1" colspan="1">rs3829817</td><td rowspan="1" colspan="1">8067450</td><td rowspan="1" colspan="1">0.26 (0.22)</td><td rowspan="1" colspan="1">0.61 (0.64)</td><td rowspan="1" colspan="1">0.21</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">1.54</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.23</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">266</td><td rowspan="1" colspan="1">292</td></tr><tr><td rowspan="1" colspan="1">rs3865464</td><td rowspan="1" colspan="1">8074340</td><td rowspan="1" colspan="1">1.08 (1.08)</td><td rowspan="1" colspan="1">0.30 (0.30)</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">0.50</td><td rowspan="1" colspan="1">1.23</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">0.90</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">308</td><td rowspan="1" colspan="1">340</td></tr><tr><td rowspan="1" colspan="1">rs33967815</td><td rowspan="1" colspan="1">8074545</td><td rowspan="1" colspan="1">0.03 (0.06)</td><td rowspan="1" colspan="1">0.85 (0.81)</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">1.03</td><td rowspan="1" colspan="1">0.76</td><td rowspan="1" colspan="1">1.40</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1">0.31</td><td rowspan="1" colspan="1">111</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1">0.68</td><td rowspan="1" colspan="1">0.69</td><td rowspan="1" colspan="1">235</td><td rowspan="1" colspan="1">266</td></tr><tr><td rowspan="1" colspan="1">rs10445638</td><td rowspan="1" colspan="1">8079428</td><td rowspan="1" colspan="1">0.07 (0.07)</td><td rowspan="1" colspan="1">0.79 (0.79)</td><td rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1">0.93</td><td rowspan="1" colspan="1">0.55</td><td rowspan="1" colspan="1">1.57</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">0.91</td><td rowspan="1" colspan="1">0.91</td><td rowspan="1" colspan="1">309</td><td rowspan="1" colspan="1">353</td></tr><tr><td rowspan="1" colspan="1">rs3813779</td><td rowspan="1" colspan="1">8080650</td><td rowspan="1" colspan="1">0.68 (0.57)</td><td rowspan="1" colspan="1">0.41 (45)</td><td rowspan="1" colspan="1">0.39</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">1.18</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.47</td><td rowspan="1" colspan="1">150</td><td rowspan="1" colspan="1">181</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">194</td><td rowspan="1" colspan="1">207</td></tr><tr><td rowspan="1" colspan="1">rs8111335</td><td rowspan="1" colspan="1">8082361</td><td rowspan="1" colspan="1">1.80 (1.81)</td><td rowspan="1" colspan="1">0.18 (0.18)</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">1.32</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">2.02</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">283</td><td rowspan="1" colspan="1">335</td></tr><tr><td rowspan="1" colspan="1">rs12975322</td><td rowspan="1" colspan="1">8082640</td><td rowspan="1" colspan="1">0.88 (0.88)</td><td rowspan="1" colspan="1">0.35 (0.35)</td><td rowspan="1" colspan="1">0.46</td><td rowspan="1" colspan="1">1.18</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">1.67</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.22</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">269</td><td rowspan="1" colspan="1">292</td></tr><tr><td rowspan="1" colspan="1">rs4804063</td><td rowspan="1" colspan="1">8082945</td><td rowspan="1" colspan="1">0.38 (0.38)</td><td rowspan="1" colspan="1">0.54 (0.54)</td><td rowspan="1" colspan="1">0.27</td><td rowspan="1" colspan="1">0.89</td><td rowspan="1" colspan="1">0.62</td><td rowspan="1" colspan="1">1.28</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">0.81</td><td rowspan="1" colspan="1">285</td><td rowspan="1" colspan="1">313</td></tr><tr><td rowspan="1" colspan="1">rs2086149</td><td rowspan="1" colspan="1">8083620</td><td rowspan="1" colspan="1">0.03 (0.05)</td><td rowspan="1" colspan="1">0.87 (0.83)</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">0.71</td><td rowspan="1" colspan="1">1.33</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.30</td><td rowspan="1" colspan="1">0.30</td><td rowspan="1" colspan="1">104</td><td rowspan="1" colspan="1">114</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">240</td><td rowspan="1" colspan="1">270</td></tr><tr><td rowspan="1" colspan="1">rs35579498</td><td rowspan="1" colspan="1">8089871</td><td rowspan="1" colspan="1">0.02 (0.02)</td><td rowspan="1" colspan="1">0.89 (0.89)</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">1.06</td><td rowspan="1" colspan="1">0.49</td><td rowspan="1" colspan="1">2.26</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">0.96</td><td rowspan="1" colspan="1">0.96</td><td rowspan="1" colspan="1">328</td><td rowspan="1" colspan="1">371</td></tr><tr><td rowspan="1" colspan="1">rs4527136</td><td rowspan="1" colspan="1">8092519</td><td rowspan="1" colspan="1">0.54 (0.54)</td><td rowspan="1" colspan="1">0.46 (0.46)</td><td rowspan="1" colspan="1">0.34</td><td rowspan="1" colspan="1">1.12</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">1.50</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.46</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">159</td><td rowspan="1" colspan="1">169</td><td rowspan="1" colspan="1">0.54</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">183</td><td rowspan="1" colspan="1">217</td></tr><tr><td rowspan="1" colspan="1">rs35840170</td><td rowspan="1" colspan="1">8094812</td><td rowspan="1" colspan="1">0.35 (0.35)</td><td rowspan="1" colspan="1">0.55 (0.55)</td><td rowspan="1" colspan="1">0.26</td><td rowspan="1" colspan="1">1.30</td><td rowspan="1" colspan="1">0.54</td><td rowspan="1" colspan="1">3.11</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">333</td><td rowspan="1" colspan="1">371</td></tr><tr><td rowspan="1" colspan="1">rs3813774</td><td rowspan="1" colspan="1">8102499</td><td rowspan="1" colspan="1">4.29 (4.36)</td><td rowspan="1" colspan="1">0.04 (0.04)</td><td rowspan="1" colspan="1">1.46</td><td rowspan="1" colspan="1">1.88</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">3.52</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0.95</td><td rowspan="1" colspan="1">317</td><td rowspan="1" colspan="1">370</td></tr><tr><td rowspan="1" colspan="1">rs12974280</td><td rowspan="1" colspan="1">8102508</td><td rowspan="1" colspan="1">0.09 (0.09)</td><td rowspan="1" colspan="1">0.76 (0.76)</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.95</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">1.30</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.37</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">146</td><td rowspan="1" colspan="1">0.63</td><td rowspan="1" colspan="1">0.62</td><td rowspan="1" colspan="1">217</td><td rowspan="1" colspan="1">242</td></tr><tr><td rowspan="1" colspan="1">rs8112525</td><td rowspan="1" colspan="1">8107051</td><td rowspan="1" colspan="1">0.27 (0.29)</td><td rowspan="1" colspan="1">0.61 (0.59)</td><td rowspan="1" colspan="1">0.21</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">0.54</td><td rowspan="1" colspan="1">1.42</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">0.90</td><td rowspan="1" colspan="1">0.91</td><td rowspan="1" colspan="1">309</td><td rowspan="1" colspan="1">353</td></tr><tr><td rowspan="1" colspan="1">rs2061776</td><td rowspan="1" colspan="1">8108373</td><td rowspan="1" colspan="1">0.17 (0.17)</td><td rowspan="1" colspan="1">0.68 (0.68)</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.71</td><td rowspan="1" colspan="1">1.67</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">0.85</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">290</td><td rowspan="1" colspan="1">325</td></tr><tr><td rowspan="1" colspan="1">rs7246376</td><td rowspan="1" colspan="1">8109328</td><td rowspan="1" colspan="1">0.12 (0.12)</td><td rowspan="1" colspan="1">0.73 (0.73)</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">0.94</td><td rowspan="1" colspan="1">0.66</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1">0.21</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">0.79</td><td rowspan="1" colspan="1">275</td><td rowspan="1" colspan="1">308</td></tr><tr><td rowspan="1" colspan="1">rs12162237</td><td rowspan="1" colspan="1">8113070</td><td rowspan="1" colspan="1">1.64 (1.64)</td><td rowspan="1" colspan="1">0.20 (0.20)</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">1.21</td><td rowspan="1" colspan="1">0.90</td><td rowspan="1" colspan="1">1.62</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.48</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">166</td><td rowspan="1" colspan="1">168</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">178</td><td rowspan="1" colspan="1">218</td></tr><tr><td rowspan="1" colspan="1">rs7252584</td><td rowspan="1" colspan="1">8113241</td><td rowspan="1" colspan="1">2.36 (2.36)</td><td rowspan="1" colspan="1">0.12 (0.12)</td><td rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">0.50</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">59</td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">0.85</td><td rowspan="1" colspan="1">273</td><td rowspan="1" colspan="1">325</td></tr><tr><td rowspan="1" colspan="1">rs7256533</td><td rowspan="1" colspan="1">8113721</td><td rowspan="1" colspan="1">0.29 (0.29)</td><td rowspan="1" colspan="1">0.59 (0.59)</td><td rowspan="1" colspan="1">0.23</td><td rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0.69</td><td rowspan="1" colspan="1">1.23</td><td rowspan="1" colspan="1">1 (1)</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.46</td><td rowspan="1" colspan="1">150</td><td rowspan="1" colspan="1">178</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">0.54</td><td rowspan="1" colspan="1">190</td><td rowspan="1" colspan="1">208</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup>Reference SNP cluster ID.</p></fn><fn><p><sup>b</sup>Position of nucleotide on chromosome 19 in Build 35 of the human genome from UCSC (<uri xlink:type="simple" xlink:href="www.genome.ucsc.edu">www.genome.ucsc.edu</uri>).</p></fn><fn><p><sup>c</sup>Chi-squared values calculated using unphased 3.0.10 software.</p></fn><fn><p><sup>d</sup><italic>P</italic>-value of odds ratio.</p></fn><fn><p><sup>e</sup>Odds ratios were calculated using unphased 3.0.10 software.</p></fn><fn><p><sup>f</sup>Lower bound on the 95% confidence interval for the odds ratio.</p></fn><fn><p><sup>g</sup>Upper bound on the 95% confidence interval for the odds ratio.</p></fn><fn><p><sup>h</sup><italic>P</italic>-value corrected for multiple testing (Bonferroni correction).</p></fn><fn><p><sup>i</sup>Number of alleles in control subjects.</p></fn><fn><p><sup>j</sup>Number of alleles in case subjects.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3a3"><title>Haplotype association and linkage analyses</title><p>In order to increase the potential to identify a PCOS-associated SNP in the <italic>FBN3</italic> genomic region we also performed LD haplotype association analyses using Haploview software (<xref ref-type="bibr" rid="GAP072C4">Barrett <italic>et al</italic>., 2005</xref>). Haplotype association analysis can increase power to detect a signal from other unknown SNPs (not in current databases) by performing the association test on haplotype groups rather than individual SNPs. Four haplotype blocks with 18 haplotypes were identified by Haploview using the method described by <xref ref-type="bibr" rid="GAP072C14">Gabriel <italic>et al</italic>. (2002</xref>) (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F2">2</xref>a). Haplotype association frequencies, haplotype population frequencies and <italic>D</italic>&#x02032; scores of these haplotype blocks are shown in Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F2">2</xref>. Haplotype analysis failed to identify haplotypes that show significant association with PCOS. Given that the marker that led us to examine SNPs in <italic>FBN3</italic> (the microsatellite D19S884) is located in a region of low LD (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F2">2</xref> and <xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>), this result is perhaps not surprising as haplotype blocks do not by definition exist in regions of low LD.</p><fig id="GAP072F2" position="float"><label>Figure&#x000a0;2</label><caption><p>(<bold>A</bold>) Haplotypes predicted by Haploview. Four blocks were observed with the haplotpes of each block shown. Darker lines between haplotypes indicate a higher percentage of association with the linked haplotypes. Haplotype frequencies are indicated in red. <italic>D</italic>&#x02032; values for LD are indicated below each haplotype block. Chromosomal positions were taken from those reported for build 35 of the UCSC genome website (<uri xlink:type="simple" xlink:href="http://www.genome.ucsc.edu/">http://www.genome.ucsc.edu/</uri>). (<bold>B</bold>) Haploview generated graphic analysis of LD in an 82 kb region of chromosome 19 spanning <italic>FBN3</italic>. The relative position of each of the 31 markers (30 SNPs and D19S884, which is indicated with an arrow) on chromosome 19p13.2 is indicated by the vertical lines on the <bold>c</bold>hromosomal map (top) and the proportion of LD (displayed as <italic>D</italic>&#x02032;/LOD) is displayed below each marker. Haplotype blocks are indicated by dark lines. Strong LD (<italic>D</italic>&#x02032; = 1, LOD &#x02265; 2) is indicated by red, lighter shades pink indicate varying degrees of LD with lighter shades displaying less than darker (<italic>D</italic>&#x02032; &#x0003c; 1, LOD &#x02265; 2) and white indicates low LD (<italic>D</italic>&#x02032; &#x0003c; 1, LOD &#x0003c; 2).</p></caption><graphic xlink:href="gap07202"/></fig></sec><sec id="s3a4"><title>Microsatellite D19S884 association analysis</title><p>As we were unable to demonstrate association between the SNPs that we typed in the <italic>FBN3</italic> region and PCOS, we decided to genotype our patient&#x02013;control cohort for the previously associated microsatellite marker D19S884. Microsatellite D19S884 allele frequencies for the study group are shown in Table&#x000a0;<xref ref-type="table" rid="GAP072TB4">IV</xref>. The numbers of CA repeats ranged from 14 to 24 in our cohort, and repeats of 22, 17, 18 and 20 were the most common at 26&#x02013;27, 17, 12&#x02013;13 and 11%, respectively. The frequencies of each allele reported here are similar to those published previously (Table&#x000a0;<xref ref-type="table" rid="GAP072TB4">IV</xref>).</p><table-wrap id="GAP072TB4" position="float"><label>Table&#x000a0;IV</label><caption><p>For each allele in microsatellite D19S884 this table lists information on the sizes of the amplicons using either the current primers or those for amplimer AFMa299zc5, the numbers of CA repeats, the identification numbers ascribed to alleles by a previous study (<xref ref-type="bibr" rid="GAP072C46">Urbanek <italic>et al</italic>., 2005</xref>), the frequencies of each allele listed in Genbank and in a previous study (<xref ref-type="bibr" rid="GAP072C49">Villuendas <italic>et al</italic>., 2003</xref>) and that obtained in the current experiment, and the <italic>P</italic>-value for association of an allele with PCOS calculated using Fisher's exact test</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Amplicon sizes*<hr/></th><th align="left" rowspan="3" colspan="1">Number of CA repeats</th><th align="left" colspan="2" rowspan="1">Allele identification number<hr/></th><th align="left" colspan="10" rowspan="1">Allele frequency<hr/></th></tr><tr><th align="left" rowspan="2" colspan="1">Current data</th><th align="left" rowspan="2" colspan="1">Amplimer AFMa299zc5</th><th align="left" rowspan="2" colspan="1">Urbanek <italic>et al</italic>.</th><th align="left" rowspan="2" colspan="1">Genbank</th><th align="left" rowspan="2" colspan="1">Genbank&#x02020;</th><th align="left" colspan="2" rowspan="1">Data of Villuendas <italic>et al</italic>.<hr/></th><th align="left" colspan="7" rowspan="1">Current data<hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Controls</th><th align="left" rowspan="1" colspan="1">PCOS</th><th align="left" rowspan="1" colspan="1">Controls (number of alleles)</th><th align="left" rowspan="1" colspan="1">PCOS (number of alleles)</th><th align="left" rowspan="1" colspan="1"><italic>P-</italic>value<sup>a</sup></th><th align="left" rowspan="1" colspan="1">Odds ratio</th><th align="left" rowspan="1" colspan="1">95% low<sup>b</sup></th><th align="left" rowspan="1" colspan="1">95% high<sup>c</sup></th><th align="left" rowspan="1" colspan="1">Corrected <italic>P</italic>-value<sup>d</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">214</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">216</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">160</td><td rowspan="1" colspan="1">218</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">A5</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">0.09 (33)</td><td rowspan="1" colspan="1">0.06 (21)</td><td rowspan="1" colspan="1">0.26</td><td rowspan="1" colspan="1">1.44</td><td rowspan="1" colspan="1">1.22</td><td rowspan="1" colspan="1">1.69</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">162</td><td rowspan="1" colspan="1">220</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">A6</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">0.02 (6)</td><td rowspan="1" colspan="1">0.01 (5)</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">2.22</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">164</td><td rowspan="1" colspan="1">222</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">A7</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.10 (38)</td><td rowspan="1" colspan="1">0.12 (40)</td><td rowspan="1" colspan="1">0.47</td><td rowspan="1" colspan="1">0.83</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">0.93</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">166</td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">A8</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.17 (64)</td><td rowspan="1" colspan="1">0.17 (60)</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">0.94</td><td rowspan="1" colspan="1">0.87</td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">168</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">A9</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">0.12 (46)</td><td rowspan="1" colspan="1">0.13 (44)</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">170</td><td rowspan="1" colspan="1">228</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">A10</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.06 (22)</td><td rowspan="1" colspan="1">0.03 (9)</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">2.25</td><td rowspan="1" colspan="1">1.64</td><td rowspan="1" colspan="1">3.09</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="1" colspan="1">172</td><td rowspan="1" colspan="1">230</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">A11</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1">0.11 (42)</td><td rowspan="1" colspan="1">0.11 (42)</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">1.10</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">174</td><td rowspan="1" colspan="1">232</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">A12</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.05 (18)</td><td rowspan="1" colspan="1">0.06 (20)</td><td rowspan="1" colspan="1">0.51</td><td rowspan="1" colspan="1">0.79</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">176</td><td rowspan="1" colspan="1">234</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">A13</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">0.27</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">0.26 (99)</td><td rowspan="1" colspan="1">0.27 (94)</td><td rowspan="1" colspan="1">0.62</td><td rowspan="1" colspan="1">0.92</td><td rowspan="1" colspan="1">0.87</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">178</td><td rowspan="1" colspan="1">236</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">A14</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.03 (13)</td><td rowspan="1" colspan="1">0.01 (4)</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">2.96</td><td rowspan="1" colspan="1">1.54</td><td rowspan="1" colspan="1">5.68</td><td rowspan="1" colspan="1">0.63</td></tr><tr><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">238</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.01 (4)</td><td rowspan="1" colspan="1">0.03 (9)</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1">0.39</td><td rowspan="1" colspan="1">0.19</td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">1.00</td></tr><tr><td rowspan="1" colspan="1">182</td><td rowspan="1" colspan="1">240</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003c;0.00 (1)</td><td rowspan="1" colspan="1">0.00 (0)</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">1.00</td></tr></tbody></table><table-wrap-foot><fn><p>*To detect microsatellite D19S884 we designed different primers (Table&#x000a0;<xref ref-type="table" rid="GAP072TB1">I</xref>) to that of amplimer AFMa299zc5 listed in Genbank, hence the current amplicons differ in size.</p></fn><fn><p><sup>&#x02020;</sup>Frequencies of alleles listed in Genbank are from 8 CEPH families composed of 56 individuals as described for the microsatellite polymorphism rs3222751 under reference submission ss4914553.</p></fn><fn><p><sup>a</sup><italic>P</italic>-value for association of a microsatellite allele with PCOS calculated by Fisher's exact test.</p></fn><fn><p><sup>b</sup>Lower bound on the 95% confidence interval for the odds ratio.</p></fn><fn><p><sup>c</sup>Upper bound on the 95% confidence interval for the odds ratio.</p></fn><fn><p><sup>d</sup><italic>P</italic>-value corrected for multiple testing (Bonferroni correction).</p></fn></table-wrap-foot></table-wrap><p>Microsatellite allele association analyses were performed using Fisher's exact test and the Clump program. Fisher's exact test did not identify any alleles of D19S884 that were significantly associated with PCOS. Allele 10 (19 CA repeats) was the only allele that was significant (<italic>P</italic> = 0.04 uncorrected), however, upon correction for multiple testing this <italic>P</italic>-value no longer approached significance (<italic>P</italic> = 0.52) (Table&#x000a0;<xref ref-type="table" rid="GAP072TB4">IV</xref>). Clump analysis of D19S884 failed to identify association between any of the 11 alleles detected and PCOS (data not shown).</p></sec></sec><sec id="s3b"><title>FBN and LTBP expression in human ovaries</title><p>We examined the expression of <italic>FBN1, 2 and 3</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F3">3</xref>), and <italic>LTBP-1</italic> and <italic>-2</italic> mRNA (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F4">4</xref>) in normal human ovarian tissues including stroma/cortex (<italic>n</italic> = 9 non-PCO and 4 PCO ovarian phenotype), follicles (<italic>n</italic> = 3) and corpora lutea (<italic>n</italic> = 3) and ovarian cell lines. Expression levels for each gene were not significantly different between stroma, follicles and corpora lutea. <italic>FBN1</italic> mRNA levels were 50&#x02013;100 times greater than <italic>FBN2</italic> and 200&#x02013;1000-fold higher than <italic>FBN3</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F3">3</xref>). The granulosa tumour cell line KGN displayed similar levels of <italic>FBN1</italic> and <italic>2</italic> but lower levels of <italic>FBN3</italic> expression when compared with normal ovarian tissue samples (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F3">3</xref>). OVCAR-3, OVCAR-5 and SKOV-3 had lower levels of <italic>FBN1</italic> than normal ovarian tissues and KGN cells (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F3">3</xref>). OVCAR-3 cells had very high levels of expression of both <italic>FBN2</italic> and <italic>3</italic> expression compared with the other cell lines and the ovarian tissues (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F3">3</xref>).</p><fig id="GAP072F3" position="float"><label>Figure&#x000a0;3</label><caption><p>Expression of <italic>FBN1</italic> (<bold>A</bold>), <italic>FBN2</italic> (<bold>B</bold>) and <italic>FBN3</italic> (<bold>C</bold>) mRNA in human ovarian tissues and from the human ovarian tumour cell lines KGN, OVCAR-3, OVCAR-5 and SKOV-3. Data are presented as the mean values &#x000b1; SEM expressed as fmoles RNA/nmole 18S ribosomal RNA, <italic>n</italic> = 4, 9, 3 and 3 for the PCO stroma/cortex and non-PCO stroma/cortex, follicles and corpora lutea (CL), respectively.</p></caption><graphic xlink:href="gap07203"/></fig><fig id="GAP072F4" position="float"><label>Figure&#x000a0;4</label><caption><p>Expression of <italic>LTBP-1</italic> (<bold>A</bold>) and <italic>LTBP-2</italic> (<bold>B</bold>) mRNA in human ovarian tissues and from the human ovarian tumour cell lines KGN, OVCAR-3, OVCAR-5 and SKOV-3. Data are presented as the mean values &#x000b1; SEM expressed as fmoles RNA/nmole 18S ribosomal RNA, <italic>n</italic> = 4, 9, 3 and 3 for the PCO stroma/cortex and non-PCO stroma/cortex, follicles and corpora lutea (CL), respectively.</p></caption><graphic xlink:href="gap07204"/></fig><p><italic>LTBP-1</italic> expression levels were &#x0003e;3-fold greater than <italic>LTBP-2</italic> in normal ovarian tissues (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F4">4</xref>). OVCAR-3, OVCAR-5 and SKOV-3 had lower levels of <italic>LTBP-2</italic> than normal ovarian tissues, but <italic>LTBP-1</italic> expression was variable across the cell lines; with OVCAR-3 having the highest levels of expression (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F4">4</xref>). Correlation analyses were conducted and <italic>FBN1</italic> expression significantly correlated with <italic>FBN2</italic> (<italic>P</italic> &#x0003c; 0.001) and LT<italic>BP-1</italic> (<italic>P</italic> &#x0003c; 0.01) and <italic>FBN2</italic> with <italic>LTBP-1</italic> (<italic>P</italic> &#x0003c; 0.001) across all tissues (Fig.&#x000a0;<xref ref-type="fig" rid="GAP072F5">5</xref>).</p><fig id="GAP072F5" position="float"><label>Figure&#x000a0;5</label><caption><p>Scatter plots of (<bold>A</bold>) <italic>FBN2</italic> versus <italic>FBN1</italic>, (<bold>B</bold>) <italic>LTBP-1</italic> versus <italic>FBN1</italic> and (<bold>C</bold>) <italic>LTBP-1</italic> versus <italic>FBN2</italic> mRNA expression (fmoles/nmole 18S ribosomal RNA) using human ovarian tissues (excluding cell lines; <italic>n</italic> = 19). The <italic>P</italic>-values and correlation coefficient (<italic>R</italic>) relate to correlation with a Pearson's two-tailed test.</p></caption><graphic xlink:href="gap07205"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>We have conducted a case&#x02013;control study of PCOS examining the genotypes of 30 SNPs, including 10 functional SNPs, in an 82 kb region of chromosome 19 flanking <italic>FBN3</italic>. In our cohort, we also genotyped the microsatellite marker D19S884, previously reported to be associated with PCOS by familial linkage analyses and located within intron 55 of <italic>FBN3</italic>. In addition, we examined the expression of the three <italic>FBN</italic>s and two of the <italic>LTBP</italic>s (<italic>LTBP-1</italic> and <italic>-2</italic>) in ovarian tissues. We conclude that if <italic>FBN3</italic> is involved in the aetiology of PCOS then its role is not readily apparent from these studies.</p><p>Tagging SNPs were chosen to span an 82 kb region of the <italic>FBN3</italic> gene, which flanks the previously associated microsatellite marker D19S884, such that &#x0223c;100% of SNP alleles with minor allele frequencies &#x0003e;5% in this region were captured with an <italic>r</italic><sup>2</sup> value of &#x0003e;0.8. Thus, we would have expected to have been able to identify any common SNP within this region of 19p13.2 that showed significant association with PCOS. None of the 30 SNPs we tested had allele frequencies that were significantly different between controls and PCOS patients once corrected for multiple testing.</p><p>Microsatellite D19S884 is located in a non-conserved intronic region that displays low levels of LD, thus it remains possible that a causal SNP is located within this region. The closest SNP markers to D19S884 (chromosomal position 8056140) that were analysed here were rs17160147 and rs1251028, which are located at 2098 bp 3&#x02032; and 8784 bp 5&#x02032; of D19S884, respectively. There is at least one other SNP (rs1246064) in this region that was not analysed, nor captured by our tagging SNPs, and is heterogeneous in the CEU population. It is, however, unlikely that this SNP is causal for PCOS as it does not result in changes to protein sequence and was not found to be associated with PCOS in another study (<xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>). There are other SNPs in this region that are heterogeneous in either African (rs8102892, rs8112982), Asian (rs8105886, rs17160153) or both populations (rs17160151, rs12984611) but these are not heterogeneous in a European population and hence unlikely to be causal in an Australian population. As we did not find any SNP in the <italic>FBN3</italic> gene region that showed any significant association with PCOS, we examined the association of the microsatellite marker D19S884 in our cohort. Previous studies identified allele 8 (17 CA di-nucleotide repeats) as segregating with PCOS (<xref ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>). However, we were unable to identify any allele of the microsatellite that showed any significant association with PCOS in our cohort, after correcting for multiple testing.</p><p>The results presented here would appear to be in disagreement with other studies that found strong association between D19S884 and PCOS (<xref ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>). Both studies were conducted on subjects recruited solely from the USA and who fulfilled the 1990 NIH criteria. One study (<xref ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>) was a case&#x02013;control study whereas the other (<xref ref-type="bibr" rid="GAP072C47">Urbanek <italic>et al</italic>., 2007</xref>) was a family-based study. We also recruited subjects of Caucasian background from the Australian population who fulfilled the 1990 NIH criteria for a case&#x02013;control study. It is possible but unlikely that there are differences in genetic background with regard to PCOS between the Australian population and that of the USA. While the number of subjects in our study is low, our power calculations suggest that we had enough power to detect mutations that have a moderate (0.3) effect size and our numbers are much higher (173/194 PCOS/control subjects) than two previous case&#x02013;control studies (<xref ref-type="bibr" rid="GAP072C43">Tucci <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="GAP072C49">Villuendas <italic>et al</italic>., 2003</xref>) having 85/87 and 108/66 PCOS/control subjects, respectively. Our study is therefore more likely to be reflective of population allele frequencies and less prone to sampling bias. Despite this, it is possible that our numbers were too low to detect association of D19S884 with PCOS in the Australian population.</p><p>The expression of <italic>FBN1, 2</italic> and <italic>3</italic> and <italic>LTBP-1</italic> and <italic>-2</italic> were examined in PCO ovarian stroma/cortex and non-PCO stroma/cortex, follicles and corpora lutea and clear patterns emerged. Firstly, there were no differences between stroma from ovaries with a PCO phenotype and those from non-PCO ovaries in any of the genes examined. In all the tissues examined, the expression of <italic>FBN1</italic> was far greater than <italic>FBN2</italic>, which was far greater than <italic>FBN3</italic>, which was barely detectible. A similar pattern of expression was previously observed in bovine tunica and stroma of the cortex (<xref ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>). In our previous study, we found that in the bovine ovary, the expression of <italic>FBN1</italic> within follicles was confined to the theca interna and in the tunica and stroma (corpora lutea were not examined) (<xref ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>). In the current study we found that the expression of <italic>LTBP-1</italic> was greater than that of LTBP-2, which was also observed in the bovine tunica and stroma of the cortex (<xref ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>). In bovine ovaries, the expression of <italic>LTBP-1</italic> was localized to the tunica and stroma of the cortex and in follicles in the inner area of the theca externa (<xref ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>). Additionally, the immunolocalization pattern of <italic>FBN1</italic> and <italic>LTBP-1</italic> were fibrillar in the tunica and stroma of the cortex and in the thecal layers, suggesting that they are both associated with microfibrils as has been observed previously (<xref ref-type="bibr" rid="GAP072C23">Isogai <italic>et al</italic>., 2003</xref>). Expression of <italic>FBN1</italic> and <italic>2</italic> and <italic>LTBP-1</italic> in the ovarian tissues examined here were correlated with each other. In bovine tunica and cortical stromal samples all three <italic>FBN</italic>s were correlated with <italic>LTBP-2</italic> and not <italic>LTBP-1</italic> (<xref ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>). This suggests that there is some degree of coordinate regulation amongst these genes in both humans and in the bovine.</p><p>To increase our knowledge of fibrillin family members in ovaries expression was also examined in human ovarian cancer cell lines OVCAR-3, OVCAR-5 and SKOV-3 (ascites derived) derived from ovarian adenocarcinoma, and in KGN cells which have a granulosa cell phenotype (<xref ref-type="bibr" rid="GAP072C36">Nishi <italic>et al</italic>., 2001</xref>). The expression levels of <italic>FBN1, 2</italic> and <italic>3</italic> and <italic>LTBP-1</italic> in the KGN cells was generally similar to that of the other ovarian tissues examined. The expression of these genes was much lower in the OVCAR-5 and SKOV-3 cells, in agreement with the localization of <italic>FBN1</italic> and <italic>LTBP-1</italic> and <italic>-2</italic> in the bovine where no localization to the ovarian surface epithelium was observed (<xref ref-type="bibr" rid="GAP072C37">Prodoehl <italic>et al</italic>., 2009</xref>). However, OVCAR-3 had elevated levels of <italic>FBN2</italic>, <italic>3</italic>, and <italic>LTBP-1</italic> relative to normal ovarian tissues and other ovarian cancer cell lines.</p><p>It appears, from our genetic analysis, that the marker D19S884 and its associated gene, <italic>FBN3</italic>, have little or no impact on PCOS pathology in the Australian population. We cannot, however, rule out the possibility that other markers in the region of chromosome 19p13.2 are associated. Additionally our study of expression of five members of the fibrillin family in human ovaries found very low levels of <italic>FBN3</italic>, but our study also cannot rule out that alterations in <italic>FBN3</italic> expression occur in other organs or tissues such as the anterior pituitary, influencing hormonal regulation of the ovary or adipose tissue. It is also possible that a genetic lesion in the <italic>FBN3</italic> gene associated with PCOS pathology may cause functional changes in the protein's structure without affecting its expression levels. We conclude that if <italic>FBN3</italic> is involved in the aetiology of PCOS then its role is not readily apparent from these studies.</p></sec><sec id="s5"><title>Authors' Role</title><p>M.J.P., N.H., H.F.I.-R., M.A.G. and R.J.R. planned the experiments, conducted RT&#x02013;PCR, microsatellite analyses, statistical analysis and wrote the manuscript. Z.Z.Z., J.N.P. and G.W.M. conducted the SNP analysis and statistical analysis and assisted in writing the manuscript. T.E.H. and R.J.N. developed the cohort of PCOS and control patients, isolated the DNA from the lymphocytes from these patients, and reviewed the manuscript. W.E.R., B.R.C. and H.D.M. provided human ovarian samples and RNA and reviewed the manuscript.</p></sec><sec id="s6"><title>Funding</title><p>Funding to support this research was obtained from the <funding-source>National Health and Medical Research Council of Australia</funding-source>, University of Adelaide, <funding-source>the Clive and Vera Ramaciotti Foundation</funding-source>, <funding-source>the Wellcome Trust</funding-source>, and <funding-source>National Institute of Health</funding-source>, and <funding-source>Medical Research Council UK</funding-source>.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank Professors Hajime Nawata and Toshihiko Yanase of Kyushu University and Professor Yoshihiro Nishi of Kurume University for the KGN cell line, Drs Suman Rice and Laura Pellatt for ovarian tissues, and Dr Carmela Ricciardelli and Miranda Ween for the cancer cell lines. Funding to pay the Open Access publication charges for this article was provided by the National Health and Medical Research Council of Australia.</p></ack><ref-list><title>References</title><ref id="GAP072C1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>J</given-names></name><name><surname>Polson</surname><given-names>DW</given-names></name><name><surname>Franks</surname><given-names>S</given-names></name></person-group><article-title>Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism</article-title><source>Br Med J (Clin Res Ed)</source><year>1986</year><volume>293</volume><fpage>355</fpage><lpage>359</lpage></element-citation></ref><ref id="GAP072C2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>P</given-names></name><name><surname>Simpson</surname><given-names>JL</given-names></name></person-group><article-title>The genetics of polycystic ovary syndrome</article-title><source>Best Pract Res Clin Obstet Gynaecol</source><year>2004</year><volume>18</volume><fpage>707</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">15380142</pub-id></element-citation></ref><ref id="GAP072C3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balen</surname><given-names>AH</given-names></name><name><surname>Conway</surname><given-names>GS</given-names></name><name><surname>Kaltsas</surname><given-names>G</given-names></name><name><surname>Techatrasak</surname><given-names>K</given-names></name><name><surname>Manning</surname><given-names>PJ</given-names></name><name><surname>West</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>HS</given-names></name></person-group><article-title>Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients</article-title><source>Hum Reprod</source><year>1995</year><volume>10</volume><fpage>2107</fpage><lpage>2111</lpage><pub-id pub-id-type="pmid">8567849</pub-id></element-citation></ref><ref id="GAP072C4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis visualization of LD haplotype maps</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15297300</pub-id></element-citation></ref><ref id="GAP072C5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boileau</surname><given-names>C</given-names></name><name><surname>Jondeau</surname><given-names>G</given-names></name><name><surname>Mizuguchi</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name></person-group><article-title>Molecular genetics of Marfan syndrome</article-title><source>Curr Opin Cardiol</source><year>2005</year><volume>20</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">15861007</pub-id></element-citation></ref><ref id="GAP072C6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchner</surname><given-names>A</given-names></name><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfeldera</surname><given-names>E</given-names></name></person-group><source>G Power: A Priori, Post-hoc, and Compromise Power Analyses for the Macintosh. University of Trier</source><year>1997</year><comment>(<uri xlink:type="simple" xlink:href="http://www.psychouni-duesseldorfde/app/projects/gpower">http://www.psychouni-duesseldorfde/app/projects/gpower</uri>)</comment></element-citation></ref><ref id="GAP072C7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carey</surname><given-names>AH</given-names></name><name><surname>Waterworth</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Little</surname><given-names>J</given-names></name><name><surname>Novelli</surname><given-names>P</given-names></name><name><surname>Franks</surname><given-names>S</given-names></name><name><surname>Williamson</surname><given-names>R</given-names></name></person-group><article-title>Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17</article-title><source>Hum Mol Genet</source><year>1994</year><volume>3</volume><fpage>1873</fpage><lpage>1876</lpage><pub-id pub-id-type="pmid">7849715</pub-id></element-citation></ref><ref id="GAP072C8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christner</surname><given-names>PJ</given-names></name><name><surname>Ayitey</surname><given-names>S</given-names></name></person-group><article-title>Extracellular matrix containing mutated fibrillin-1 (Fbn1) down regulates Col1a1, Col1a2, Col3a1, Col5a1, and Col5a2 mRNA levels in Tsk/+ and Tsk/Tsk embryonic fibroblasts</article-title><source>Amino Acids</source><year>2006</year><volume>30</volume><fpage>445</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">16583319</pub-id></element-citation></ref><ref id="GAP072C9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>GS</given-names></name><name><surname>Honour</surname><given-names>JW</given-names></name><name><surname>Jacobs</surname><given-names>HS</given-names></name></person-group><article-title>Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients</article-title><source>Clin Endocrinol (Oxf)</source><year>1989</year><volume>30</volume><fpage>459</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">2688996</pub-id></element-citation></ref><ref id="GAP072C10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corson</surname><given-names>GM</given-names></name><name><surname>Charbonneau</surname><given-names>NL</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Sakai</surname><given-names>LY</given-names></name></person-group><article-title>Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues</article-title><source>Genomics</source><year>2004</year><volume>83</volume><fpage>461</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">14962672</pub-id></element-citation></ref><ref id="GAP072C11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamanti-Kandarakis</surname><given-names>E</given-names></name><name><surname>Kouli</surname><given-names>CR</given-names></name><name><surname>Bergiele</surname><given-names>AT</given-names></name><name><surname>Filandra</surname><given-names>FA</given-names></name><name><surname>Tsianateli</surname><given-names>TC</given-names></name><name><surname>Spina</surname><given-names>GG</given-names></name><name><surname>Zapanti</surname><given-names>ED</given-names></name><name><surname>Bartzis</surname><given-names>MI</given-names></name></person-group><article-title>A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>4006</fpage><lpage>4011</lpage><pub-id pub-id-type="pmid">10566641</pub-id></element-citation></ref><ref id="GAP072C12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudbridge</surname><given-names>F</given-names></name></person-group><article-title>Likelihood-for nuclear families and unrelated subjects with missing genotype data</article-title><source>Hum Hered</source><year>2008</year><volume>66</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">18382088</pub-id></element-citation></ref><ref id="GAP072C13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franks</surname><given-names>S</given-names></name></person-group><article-title>Polycystic ovary syndrome</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><fpage>853</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">7651477</pub-id></element-citation></ref><ref id="GAP072C14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Schaffner</surname><given-names>SF</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Moore</surname><given-names>JM</given-names></name><name><surname>Roy</surname><given-names>J</given-names></name><name><surname>Blumenstiel</surname><given-names>B</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>DeFelice</surname><given-names>M</given-names></name><name><surname>Lochner</surname><given-names>A</given-names></name><name><surname>Faggart</surname><given-names>M</given-names></name><etal/></person-group><article-title>The structure of haplotype blocks in the human genome</article-title><source>Science (New York, NY)</source><year>2002</year><volume>296</volume><fpage>2225</fpage><lpage>2229</lpage></element-citation></ref><ref id="GAP072C15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gharani</surname><given-names>N</given-names></name><name><surname>Waterworth</surname><given-names>DM</given-names></name><name><surname>Batty</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Gilling-Smith</surname><given-names>C</given-names></name><name><surname>Conway</surname><given-names>GS</given-names></name><name><surname>McCarthy</surname><given-names>M</given-names></name><name><surname>Franks</surname><given-names>S</given-names></name><name><surname>Williamson</surname><given-names>R</given-names></name></person-group><article-title>Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism</article-title><source>Hum Mol Genet</source><year>1997</year><volume>6</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">9147642</pub-id></element-citation></ref><ref id="GAP072C16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>MA</given-names></name><name><surname>Hatzinikolas</surname><given-names>G</given-names></name><name><surname>Davis</surname><given-names>EC</given-names></name><name><surname>Baker</surname><given-names>E</given-names></name><name><surname>Sutherland</surname><given-names>GR</given-names></name><name><surname>Mecham</surname><given-names>RP</given-names></name></person-group><article-title>Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils</article-title><source>Mol Cell Biol</source><year>1995</year><volume>15</volume><fpage>6932</fpage><lpage>6942</lpage><pub-id pub-id-type="pmid">8524260</pub-id></element-citation></ref><ref id="GAP072C17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giltay</surname><given-names>R</given-names></name><name><surname>Kostka</surname><given-names>G</given-names></name><name><surname>Timpl</surname><given-names>R</given-names></name></person-group><article-title>Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-beta binding proteins</article-title><source>FEBS Lett</source><year>1997</year><volume>411</volume><fpage>164</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">9271198</pub-id></element-citation></ref><ref id="GAP072C18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glister</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>SL</given-names></name><name><surname>Knight</surname><given-names>PG</given-names></name></person-group><article-title>Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><fpage>1883</fpage><lpage>1892</lpage><pub-id pub-id-type="pmid">15625241</pub-id></element-citation></ref><ref id="GAP072C19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glister</surname><given-names>C</given-names></name><name><surname>Groome</surname><given-names>NP</given-names></name><name><surname>Knight</surname><given-names>PG</given-names></name></person-group><article-title>Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid</article-title><source>J Endocrinol</source><year>2006</year><volume>188</volume><fpage>215</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">16461548</pub-id></element-citation></ref><ref id="GAP072C20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govinden</surname><given-names>R</given-names></name><name><surname>Bhoola</surname><given-names>KD</given-names></name></person-group><article-title>Genealogy expression cellular function of transforming growth factor-beta</article-title><source>Pharmacol Ther</source><year>2003</year><volume>98</volume><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">12725873</pub-id></element-citation></ref><ref id="GAP072C21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirani</surname><given-names>R</given-names></name><name><surname>Hanssen</surname><given-names>E</given-names></name><name><surname>Gibson</surname><given-names>MA</given-names></name></person-group><article-title>LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 competes with LTBP-1 for binding to this microfibrillar protein</article-title><source>Matrix Biol</source><year>2007</year><volume>26</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">17293099</pub-id></element-citation></ref><ref id="GAP072C22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughesdon</surname><given-names>PE</given-names></name></person-group><article-title>Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called &#x0201c;hyperthecosis&#x0201d;</article-title><source>Obstet Gynecol Surv</source><year>1982</year><volume>37</volume><fpage>59</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">7033852</pub-id></element-citation></ref><ref id="GAP072C23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isogai</surname><given-names>Z</given-names></name><name><surname>Ono</surname><given-names>RN</given-names></name><name><surname>Ushiro</surname><given-names>S</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Mazzieri</surname><given-names>R</given-names></name><name><surname>Charbonneau</surname><given-names>NL</given-names></name><name><surname>Reinhardt</surname><given-names>DP</given-names></name><name><surname>Rifkin</surname><given-names>DB</given-names></name><name><surname>Sakai</surname><given-names>LY</given-names></name></person-group><article-title>Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>2750</fpage><lpage>2757</lpage><pub-id pub-id-type="pmid">12429738</pub-id></element-citation></ref><ref id="GAP072C24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>MR</given-names></name><name><surname>Wilson</surname><given-names>SG</given-names></name><name><surname>Mullin</surname><given-names>BH</given-names></name><name><surname>Mead</surname><given-names>R</given-names></name><name><surname>Watts</surname><given-names>GF</given-names></name><name><surname>Stuckey</surname><given-names>BG</given-names></name></person-group><article-title>Polymorphism of the follistatin gene in polycystic ovary syndrome</article-title><source>Mol Hum Reprod</source><year>2007</year><volume>13</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">17284512</pub-id></element-citation></ref><ref id="GAP072C25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanzaki</surname><given-names>T</given-names></name><name><surname>Olofsson</surname><given-names>A</given-names></name><name><surname>Moren</surname><given-names>A</given-names></name><name><surname>Wernstedt</surname><given-names>C</given-names></name><name><surname>Hellman</surname><given-names>U</given-names></name><name><surname>Miyazono</surname><given-names>K</given-names></name><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name></person-group><article-title>TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences</article-title><source>Cell</source><year>1990</year><volume>61</volume><fpage>1051</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">2350783</pub-id></element-citation></ref><ref id="GAP072C26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kevenaar</surname><given-names>ME</given-names></name><name><surname>Laven</surname><given-names>JS</given-names></name><name><surname>Fong</surname><given-names>SL</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>de Jong</surname><given-names>FH</given-names></name><name><surname>Themmen</surname><given-names>AP</given-names></name><name><surname>Visser</surname><given-names>JA</given-names></name></person-group><article-title>A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients</article-title><source>J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><fpage>1310</fpage><lpage>1316</lpage><pub-id pub-id-type="pmid">18230658</pub-id></element-citation></ref><ref id="GAP072C27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kielty</surname><given-names>CM</given-names></name><name><surname>Sherratt</surname><given-names>MJ</given-names></name><name><surname>Shuttleworth</surname><given-names>CA</given-names></name></person-group><article-title>Elastic fibres</article-title><source>J Cell Sci</source><year>2002</year><volume>115</volume><fpage>2817</fpage><lpage>2828</lpage><pub-id pub-id-type="pmid">12082143</pub-id></element-citation></ref><ref id="GAP072C28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knochenhauer</surname><given-names>ES</given-names></name><name><surname>Key</surname><given-names>TJ</given-names></name><name><surname>Kahsar-Miller</surname><given-names>M</given-names></name><name><surname>Waggoner</surname><given-names>W</given-names></name><name><surname>Boots</surname><given-names>LR</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name></person-group><article-title>Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study</article-title><source>J Clin Endocrinol Metab</source><year>1998</year><volume>83</volume><fpage>3078</fpage><lpage>3082</lpage><pub-id pub-id-type="pmid">9745406</pub-id></element-citation></ref><ref id="GAP072C29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Godfrey</surname><given-names>M</given-names></name><name><surname>Vitale</surname><given-names>E</given-names></name><name><surname>Hori</surname><given-names>H</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Sarfarazi</surname><given-names>M</given-names></name><name><surname>Tsipouras</surname><given-names>P</given-names></name><name><surname>Ramirez</surname><given-names>F</given-names></name><name><surname>Hollister</surname><given-names>DW</given-names></name></person-group><article-title>Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes</article-title><source>Nature</source><year>1991</year><volume>352</volume><fpage>330</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">1852206</pub-id></element-citation></ref><ref id="GAP072C30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Bentley-Lewis</surname><given-names>R</given-names></name><name><surname>Driscoll</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>SC</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name></person-group><article-title>Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity</article-title><source>J Clin Endocrinol Metab</source><year>2002</year><volume>87</volume><fpage>2128</fpage><lpage>2133</lpage><pub-id pub-id-type="pmid">11994352</pub-id></element-citation></ref><ref id="GAP072C31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>HD</given-names></name><name><surname>Willis</surname><given-names>DS</given-names></name><name><surname>Beard</surname><given-names>RW</given-names></name><name><surname>Winston</surname><given-names>RM</given-names></name><name><surname>Margara</surname><given-names>R</given-names></name><name><surname>Franks</surname><given-names>S</given-names></name></person-group><article-title>Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid</article-title><source>J Clin Endocrinol Metab</source><year>1994</year><volume>79</volume><fpage>1355</fpage><lpage>1360</lpage><pub-id pub-id-type="pmid">7962330</pub-id></element-citation></ref><ref id="GAP072C32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milner</surname><given-names>CR</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name><name><surname>Hussey</surname><given-names>ND</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name></person-group><article-title>No association between the -308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries</article-title><source>Mol Hum Reprod</source><year>1999</year><volume>5</volume><fpage>5</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10050654</pub-id></element-citation></ref><ref id="GAP072C33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazono</surname><given-names>K</given-names></name><name><surname>Olofsson</surname><given-names>A</given-names></name><name><surname>Colosetti</surname><given-names>P</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name></person-group><article-title>A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1</article-title><source>Embo J</source><year>1991</year><volume>10</volume><fpage>1091</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">2022183</pub-id></element-citation></ref><ref id="GAP072C34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moren</surname><given-names>A</given-names></name><name><surname>Olofsson</surname><given-names>A</given-names></name><name><surname>Stenman</surname><given-names>G</given-names></name><name><surname>Sahlin</surname><given-names>P</given-names></name><name><surname>Kanzaki</surname><given-names>T</given-names></name><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name><name><surname>ten Dijke</surname><given-names>P</given-names></name><name><surname>Miyazono</surname><given-names>K</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name></person-group><article-title>Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>32469</fpage><lpage>32478</lpage><pub-id pub-id-type="pmid">7798248</pub-id></element-citation></ref><ref id="GAP072C35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neptune</surname><given-names>ER</given-names></name><name><surname>Frischmeyer</surname><given-names>PA</given-names></name><name><surname>Arking</surname><given-names>DE</given-names></name><name><surname>Myers</surname><given-names>L</given-names></name><name><surname>Bunton</surname><given-names>TE</given-names></name><name><surname>Gayraud</surname><given-names>B</given-names></name><name><surname>Ramirez</surname><given-names>F</given-names></name><name><surname>Sakai</surname><given-names>LY</given-names></name><name><surname>Dietz</surname><given-names>HC</given-names></name></person-group><article-title>Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome</article-title><source>Nat Genet</source><year>2003</year><volume>33</volume><fpage>407</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">12598898</pub-id></element-citation></ref><ref id="GAP072C36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>Y</given-names></name><name><surname>Yanase</surname><given-names>T</given-names></name><name><surname>Mu</surname><given-names>Y</given-names></name><name><surname>Oba</surname><given-names>K</given-names></name><name><surname>Ichino</surname><given-names>I</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Mukasa</surname><given-names>C</given-names></name><name><surname>Okabe</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor</article-title><source>Endocrinology</source><year>2001</year><volume>142</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">11145608</pub-id></element-citation></ref><ref id="GAP072C37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prodoehl</surname><given-names>MJ</given-names></name><name><surname>Irving-Rodgers</surname><given-names>HF</given-names></name><name><surname>Bonner</surname><given-names>W</given-names></name><name><surname>Sullivan</surname><given-names>TM</given-names></name><name><surname>Micke</surname><given-names>GC</given-names></name><name><surname>Gibson</surname><given-names>MA</given-names></name><name><surname>Perry</surname><given-names>VE</given-names></name><name><surname>Rodgers</surname><given-names>RJ</given-names></name></person-group><article-title>Fibrillins and latent TGF&#x003b2; binding proteins in bovine ovaries of offspring following high or low protein diets during pregnancy of dams</article-title><source>Mol Cell Endocrinol</source><year>2009</year><volume>307</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">19524133</pub-id></element-citation></ref><ref id="GAP072C38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>F</given-names></name><name><surname>Pereira</surname><given-names>L</given-names></name></person-group><article-title>The fibrillins</article-title><source>Int J Biochem Cell Biol</source><year>1999</year><volume>31</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">10216958</pub-id></element-citation></ref><ref id="GAP072C39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>LY</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Engvall</surname><given-names>E</given-names></name></person-group><article-title>Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils</article-title><source>J Cell Biol</source><year>1986</year><volume>103</volume><fpage>2499</fpage><lpage>2509</lpage><pub-id pub-id-type="pmid">3536967</pub-id></element-citation></ref><ref id="GAP072C40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slowinska-Srzednicka</surname><given-names>J</given-names></name><name><surname>Zgliczynski</surname><given-names>S</given-names></name><name><surname>Wierzbicki</surname><given-names>M</given-names></name><name><surname>Srzednicki</surname><given-names>M</given-names></name><name><surname>Stopinska-Gluszak</surname><given-names>U</given-names></name><name><surname>Zgliczynski</surname><given-names>W</given-names></name><name><surname>Soszynski</surname><given-names>P</given-names></name><name><surname>Chotkowska</surname><given-names>E</given-names></name><name><surname>Bednarska</surname><given-names>M</given-names></name><name><surname>Sadowski</surname><given-names>Z</given-names></name></person-group><article-title>The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome</article-title><source>J Endocrinol Invest</source><year>1991</year><volume>14</volume><fpage>569</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">1940062</pub-id></element-citation></ref><ref id="GAP072C41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talbott</surname><given-names>E</given-names></name><name><surname>Guzick</surname><given-names>D</given-names></name><name><surname>Clerici</surname><given-names>A</given-names></name><name><surname>Berga</surname><given-names>S</given-names></name><name><surname>Detre</surname><given-names>K</given-names></name><name><surname>Weimer</surname><given-names>K</given-names></name><name><surname>Kuller</surname><given-names>L</given-names></name></person-group><article-title>Coronary heart disease risk factors in women with polycystic ovary syndrome</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1995</year><volume>15</volume><fpage>821</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">7600112</pub-id></element-citation></ref><ref id="GAP072C42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>TB</given-names></name><name><surname>Lerch</surname><given-names>TF</given-names></name><name><surname>Cook</surname><given-names>RW</given-names></name><name><surname>Woodruff</surname><given-names>TK</given-names></name><name><surname>Jardetzky</surname><given-names>TS</given-names></name></person-group><article-title>The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding</article-title><source>Dev Cell</source><year>2005</year><volume>9</volume><fpage>535</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">16198295</pub-id></element-citation></ref><ref id="GAP072C43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucci</surname><given-names>S</given-names></name><name><surname>Futterweit</surname><given-names>W</given-names></name><name><surname>Concepcion</surname><given-names>ES</given-names></name><name><surname>Greenberg</surname><given-names>DA</given-names></name><name><surname>Villanueva</surname><given-names>R</given-names></name><name><surname>Davies</surname><given-names>TF</given-names></name><name><surname>Tomer</surname><given-names>Y</given-names></name></person-group><article-title>Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>446</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">11232039</pub-id></element-citation></ref><ref id="GAP072C44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbanek</surname><given-names>M</given-names></name><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Driscoll</surname><given-names>DA</given-names></name><name><surname>Azziz</surname><given-names>R</given-names></name><name><surname>Ehrmann</surname><given-names>DA</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names><suffix>3rd</suffix></name><name><surname>Spielman</surname><given-names>RS</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name></person-group><article-title>Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>8573</fpage><lpage>8578</lpage><pub-id pub-id-type="pmid">10411917</pub-id></element-citation></ref><ref id="GAP072C45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbanek</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Vickery</surname><given-names>KR</given-names></name><name><surname>Kao</surname><given-names>LC</given-names></name><name><surname>Christenson</surname><given-names>LK</given-names></name><name><surname>Schneyer</surname><given-names>A</given-names></name><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Driscoll</surname><given-names>DA</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names><suffix>3rd</suffix></name><name><surname>Dunaif</surname><given-names>A</given-names></name><etal/></person-group><article-title>Allelic variants of the follistatin gene in polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2000</year><volume>85</volume><fpage>4455</fpage><lpage>4461</lpage><pub-id pub-id-type="pmid">11134093</pub-id></element-citation></ref><ref id="GAP072C46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbanek</surname><given-names>M</given-names></name><name><surname>Woodroffe</surname><given-names>A</given-names></name><name><surname>Ewens</surname><given-names>KG</given-names></name><name><surname>Diamanti-Kandarakis</surname><given-names>E</given-names></name><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names><suffix>3rd</suffix></name><name><surname>Dunaif</surname><given-names>A</given-names></name><name><surname>Spielman</surname><given-names>RS</given-names></name></person-group><article-title>Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>6623</fpage><lpage>6629</lpage><pub-id pub-id-type="pmid">16091490</pub-id></element-citation></ref><ref id="GAP072C47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbanek</surname><given-names>M</given-names></name><name><surname>Sam</surname><given-names>S</given-names></name><name><surname>Legro</surname><given-names>RS</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name></person-group><article-title>Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>4191</fpage><lpage>4198</lpage><pub-id pub-id-type="pmid">17785364</pub-id></element-citation></ref><ref id="GAP072C48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verrecchia</surname><given-names>F</given-names></name><name><surname>Mauviel</surname><given-names>A</given-names></name></person-group><article-title>TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression</article-title><source>Cell Signal</source><year>2004</year><volume>16</volume><fpage>873</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">15157666</pub-id></element-citation></ref><ref id="GAP072C49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villuendas</surname><given-names>G</given-names></name><name><surname>Escobar-Morreale</surname><given-names>HF</given-names></name><name><surname>Tosi</surname><given-names>F</given-names></name><name><surname>Sancho</surname><given-names>J</given-names></name><name><surname>Moghetti</surname><given-names>P</given-names></name><name><surname>San Millan</surname><given-names>JL</given-names></name></person-group><article-title>Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome</article-title><source>Fertil Steril</source><year>2003</year><volume>79</volume><fpage>219</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">12524094</pub-id></element-citation></ref><ref id="GAP072C50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Simon</surname><given-names>TC</given-names></name><name><surname>Strebeck</surname><given-names>F</given-names></name><name><surname>Chaudhary</surname><given-names>L</given-names></name><name><surname>Morrissey</surname><given-names>J</given-names></name><name><surname>Liapis</surname><given-names>H</given-names></name><name><surname>Klahr</surname><given-names>S</given-names></name><name><surname>Hruska</surname><given-names>KA</given-names></name></person-group><article-title>Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy</article-title><source>Kidney Int</source><year>2003</year><volume>63</volume><fpage>2037</fpage><lpage>2049</lpage><pub-id pub-id-type="pmid">12753291</pub-id></element-citation></ref><ref id="GAP072C51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>DL</given-names></name><name><surname>Church</surname><given-names>DM</given-names></name><name><surname>Federhen</surname><given-names>S</given-names></name><name><surname>Lash</surname><given-names>AE</given-names></name><name><surname>Madden</surname><given-names>TL</given-names></name><name><surname>Pontius</surname><given-names>JU</given-names></name><name><surname>Schuler</surname><given-names>GD</given-names></name><name><surname>Schriml</surname><given-names>LM</given-names></name><name><surname>Sequeira</surname><given-names>E</given-names></name><name><surname>Tatusova</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Database resources of the National Center for Biotechnology</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12519941</pub-id></element-citation></ref><ref id="GAP072C52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>RA</given-names></name><name><surname>Bartholomew</surname><given-names>MJ</given-names></name></person-group><article-title>The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome</article-title><source>Am J Obstet Gynecol</source><year>1988</year><volume>159</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">2970222</pub-id></element-citation></ref><ref id="GAP072C53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>RA</given-names></name><name><surname>Painter</surname><given-names>PC</given-names></name><name><surname>Coulson</surname><given-names>PB</given-names></name><name><surname>Carruth</surname><given-names>KB</given-names></name><name><surname>Ranney</surname><given-names>GB</given-names></name></person-group><article-title>Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>1985</year><volume>61</volume><fpage>946</fpage><lpage>951</lpage><pub-id pub-id-type="pmid">4044782</pub-id></element-citation></ref><ref id="GAP072C54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>RA</given-names></name><name><surname>Alaupovic</surname><given-names>P</given-names></name><name><surname>Parker</surname><given-names>IJ</given-names></name></person-group><article-title>Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance</article-title><source>Am J Obstet Gynecol</source><year>1992</year><volume>166</volume><fpage>1191</fpage><lpage>1196</lpage><comment>Discussion 1196&#x02013;1197</comment><pub-id pub-id-type="pmid">1566769</pub-id></element-citation></ref><ref id="GAP072C55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yildiz</surname><given-names>BO</given-names></name><name><surname>Yarali</surname><given-names>H</given-names></name><name><surname>Oguz</surname><given-names>H</given-names></name><name><surname>Bayraktar</surname><given-names>M</given-names></name></person-group><article-title>Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><fpage>2031</fpage><lpage>2036</lpage><pub-id pub-id-type="pmid">12727950</pub-id></element-citation></ref><ref id="GAP072C56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>W</given-names></name><name><surname>Smiley</surname><given-names>E</given-names></name><name><surname>Germiller</surname><given-names>J</given-names></name><name><surname>Mecham</surname><given-names>RP</given-names></name><name><surname>Florer</surname><given-names>JB</given-names></name><name><surname>Wenstrup</surname><given-names>RJ</given-names></name><name><surname>Bonadio</surname><given-names>J</given-names></name></person-group><article-title>Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3)</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>10147</fpage><lpage>10160</lpage><pub-id pub-id-type="pmid">7730318</pub-id></element-citation></ref><ref id="GAP072C57"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zawadski</surname><given-names>JK</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Dunaif</surname><given-names>A</given-names></name><name><surname>Givens</surname><given-names>JR</given-names></name><name><surname>Haseltine</surname><given-names>FR</given-names></name></person-group><article-title>Diagnostic criteria for polycystic ovary syndrome: towards a rational approach</article-title><year>1992</year><publisher-loc>Boston</publisher-loc><publisher-name>Blackwell Scientific</publisher-name><fpage>377</fpage><lpage>384</lpage></element-citation></ref><ref id="GAP072C58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeisberg</surname><given-names>M</given-names></name><name><surname>Bottiglio</surname><given-names>C</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Maeshima</surname><given-names>Y</given-names></name><name><surname>Strutz</surname><given-names>F</given-names></name><name><surname>Muller</surname><given-names>GA</given-names></name><name><surname>Kalluri</surname><given-names>R</given-names></name></person-group><article-title>Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models</article-title><source>Am J Physiol</source><year>2003</year><volume>285</volume><fpage>F1060</fpage><lpage>F1067</lpage></element-citation></ref><ref id="GAP072C59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Le</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>James</surname><given-names>MR</given-names></name><name><surname>Treloar</surname><given-names>SA</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name></person-group><article-title>KRAS variation and risk of endometriosis</article-title><source>Mol Hum Reprod</source><year>2006</year><volume>12</volume><fpage>671</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">16973828</pub-id></element-citation></ref></ref-list></back></article>